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Resistance exercise eliciting muscle damage results in an immune response, leading to 
increases in circulating cytokines, and immune cell mobilization.  Classical monocytes 
respond to muscle damage, however, little is known about the intermediate or nonclassical 
monocyte response to resistance exercise.  Moreover, the impact of polyphenol 
supplementation in conjunction with resistance exercise on the innate immune response is 
unknown.  The purpose of this study was to examine the immune response following 
resistance exercise with (PPB) and without (PL) polyphenol supplementation.  Thirty-nine 
untrained men were randomized into three groups: PPB (n=13, 21.8±2.5yrs, 171.2±5.5cm, 
71.2±8.2kg), PL (n=15, 21.6±2.5yrs, 176.5±4.9cm, 84.0±15.7kg) or a control group (CON) 
(23.3±4.1yrs, 173.6±12.0cm, 77.8±15.6kg).  Blood samples were obtained pre- (PRE), 
immediately- (IP), 1- (1H), 5- (5H), 24- (24H), 48- (48H) and 96- (96H) hours post-
exercise (PPB/PL).  CON rested for one hour between PRE and IP blood draws.  Changes 
in granulocyte and monocyte subset proportions and adhesion characteristics (CD11b) 
were assessed via flow cytometry, while plasma cytokine concentrations and markers of 
muscle damage were analyzed via multiplex and spectrophotometric assays, respectively.  
Creatine Kinase and myoglobin were elevated at each time point for PPB and PL (p < 
0.050).  Monocyte chemoattractant protein-1 was significantly elevated at IP in PPB (p = 
0.005) and PL (p = 0.006) and significantly greater than CON at 5H (PPB: p < 0.001; PL: 
p = 0.006).  Granulocyte proportions were elevated at 1H (p < 0.001), 5H (p < 0.001) and 
24H (p = 0.005; p = 0.006) in PPB and PL, respectively.  Classical monocyte proportions 
were lower in PPB (p = 0.008) and PL (p = 0.003) than CON at IP, and significantly greater 
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than CON at 1H (PPB: p = 0.002; PL: p = 0.006).  Nonclassical monocyte proportions were 
significantly greater in PPB (p = 0.020) and PL (p = 0.028) than CON at IP.  Intermediate 
monocyte proportions were significantly greater in PPB (p = 0.034) and PL (p = 0.001) 
than CON at IP, and significantly lower than CON at 1H (PPB: p = 0.003; PL: p = 0.008).  
Intermediate monocyte proportions were also significantly greater in PPB than CON at 
24H (p = 0.016) and 48H (p = 0.007).  At PRE, CD11b expression was significantly lower 
in the PPB group than CON and PL for intermediate (p = 0.017; p = 0.045) and nonclassical 
(p < 0.001, p = 0.019) monocytes, respectively.  When groups were combined, CD11b 
expression was significantly elevated from PRE at IP (p < 0.001) and 1H (p = 0.015) on 
granulocytes.  CD11b expression on classical monocytes was significantly elevated 
compared to PRE at 1H (p < 0.001), 5H (p = 0.033) and 24H (p = 0.004) when groups were 
combined.  CD11b expression on intermediate monocytes was significantly elevated 
compared to PRE at 1H (p < 0.001) when groups were combined.  Intermediate and 
nonclassical monocyte proportions also showed significant positive correlations with 
markers of muscle damage (r = 0.361 to 0.775, p<0.05).  Results indicated that resistance 
exercise in novice lifters may elicit a selective mobilization of intermediate monocytes at 
24h and 48H, and that muscle damage may be related to increases in intermediate and 
nonclassical monocytes.  In addition, polyphenol supplementation appeared to suppress 
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CHAPTER 1: INTRODUCTION 
 
Resistance exercise performed at a sufficient intensity will result in microtrauma to skeletal 
muscle,  which may be reflected by leakage of various biomarkers from the sarcolemma 
(e.g., creatine kinase or myoglobin), increases in muscle soreness and potential decreases 
in muscle performance (Clarkson & Hubal, 2002; Jajtner et al., 2015; Paulsen et al., 2005).  
The mechanical stress associated with the exercise stimulus and the resulting tissue damage 
signals a profound non-specific immune response (Calle & Fernandez, 2010). This 
response manifests itself through increases in cytokine and chemokine production from 
skeletal muscle tissue, endothelial cells, resident macrophages, and other circulating 
immune cells (Ancuta, Moses, & Gabuzda, 2004; Ancuta et al., 2003; Brigitte et al., 2010; 
Della Gatta, Cameron-Smith, & Peake, 2014; Nieman et al., 2004).  Once released, 
cytokines and chemokines will elicit a response from the innate immune system, resulting 
in an accumulation of myeloid cells within a few hours and persist for several days 
following the muscle damaging exercise protocol (Paulsen et al., 2010). 
The infiltration of damaged tissue consists of three phases; preliminary, early and 
late, with each phase eliciting specific actions within the recovery process (Tidball & 
Villalta, 2010).  The preliminary phase primarily consists of neutrophil infiltration to the 
site of damage, which promotes an inflammatory environment (Nguyen & Tidball, 2003b; 
Pizza, Peterson, Baas, & Koh, 2005).  Subsequently, during the early phase monocytes 
become mobilized and differentiate into pro-inflammatory (M1) macrophages replacing 
neutrophils, further propagating the inflammatory environment (Chazaud, 2014; Nguyen 
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& Tidball, 2003a; Rigamonti et al., 2013; Song et al., 2000).  M1 macrophages then will 
yield to anti-inflammatory (M2) macrophages, which exhibit regenerative roles during the 
late phase of recovery (Chazaud, 2014; Song et al., 2000; Tidball & Villalta, 2010).  
Neutrophils and monocytes are preferentially recruited by specific chemokines, namely 
interleukin-8 (IL-8), monocyte chemoattractant protein-1 (MCP-1) and fractalkine 
(CX3CL1) (Ancuta et al., 2003; Hammond et al., 1995; Yadav, Saini, & Arora, 2010).  
Although macrophages are derived from circulating monocytes (Yang, Zhang, Yu, Yang, 
& Wang, 2014), evidence suggests that certain monocyte subsets typically give rise to M1 
macrophages, while others differentiate into M2 macrophages (Ancuta et al., 2003; Auffray 
et al., 2007). 
Recently, monocytes have been formally organized into a three subset paradigm 
(Ziegler-Heitbrock et al., 2010), replacing the two subset model from the late 1980’s 
(Wong et al., 2012).  Phenotypically, monocytes are identified based on their expression 
of the lipopolysaccharide (LPS) receptor, CD14 and the FcγRIIIa receptor, CD16.  Briefly, 
classical (CD14++/CD16-), intermediate (CD14++/CD16+) and nonclassical 
(CD14+/CD16++) monocytes exhibit different behaviors within the circulation (Van 
Craenenbroeck et al., 2014).  Classical monocytes display phagocytic behavior, while 
intermediate monocytes exhibit inflammatory actions and function as antigen presenting 
cells (Cros et al., 2010; Wong et al., 2011; Zawada et al., 2011).  Nonclassical monocytes 
are patrolling cells residing primarily within the marginal pool monitoring the endothelium 
(Cros et al., 2010; Wong et al., 2011; Zawada et al., 2011).  With the varied responsibilities 
of each monocyte subset, healthy individuals typically maintain 80-90% classical 
monocytes, 5-10% intermediate monocytes  and 5-10% nonclassical monocytes (Yang et 
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al., 2014).  During disease and inflammatory states, the proportion of these subsets are 
altered (Poehlmann, Schefold, Zuckermann-Becker, Volk, & Meisel, 2009; Tallone et al., 
2011; Zhu et al., 2015).  
Exercise elicits an inflammatory environment, which prompts modulation of the 
monocyte subsets (LaVoy et al., 2015; Shantsila et al., 2012).  Typically, the response to 
exercise entails a significant decrease in the proportion of classical monocytes with a 
concomitant increase in the proportion of nonclassical monocytes immediately following 
exercise (Booth et al., 2010; Radom-Aizik, Zaldivar, Haddad, & Cooper, 2014; Shantsila 
et al., 2012; Simpson et al., 2009).  Within one hour of recovery, the subsets have been 
demonstrated to return to resting levels (Booth et al., 2010), or flip responses, with an 
increased proportion of classical monocytes and decreases in the proportion of both 
intermediate and nonclassical monocytes (Simpson et al., 2009).  To the best of our 
knowledge, no studies have investigated the effect of resistance exercise on monocytes 
subsets.  Ischemic conditions that elicit acute tissue damage, such as stroke and myocardial 
infarction, have demonstrated relationships with changes in intermediate monocytes and 
markers of tissue damage (Tapp, Shantsila, Wrigley, Pamukcu, & Lip, 2012; Urra et al., 
2009).  Although speculative, a mechanical stress such as resistance exercise, which can 
result in skeletal muscle damage, may induce a similar response. 
While changes in leukocyte subsets are observed following exercise (Booth et al., 
2010; J. M. Peake, K. Suzuki, G. Wilson, et al., 2005), changes in cellular activation have 
also been demonstrated (Jajtner et al., 2014; Nielsen & Lyberg, 2004; van Eeden, Granton, 
Hards, Moore, & Hogg, 1999; Wells et al., 2016).  Macrophage-1 Antigen (MAC1), also 
referred to as Complement receptor 3 (CR3), is a β2 integrin involved in the late phases of 
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transendothelial migration of immune cells following tissue damage (Tan, 2012).  
Investigations examining the MAC1/CR3 response on both neutrophils and monocytes 
have utilized various modes of exercise (Jajtner et al., 2014; Nielsen & Lyberg, 2004; van 
Eeden et al., 1999; Wells et al., 2016).  The MAC1/CR3 response to resistance exercise on 
neutrophils has yielded primarily equivocal results (J. M. Peake, K. Suzuki, G. Wilson, et 
al., 2005; Pizza et al., 1996; Saxton, Claxton, Winter, & Pockley, 2003).  However, changes 
in the MAC1/CR3 expression on monocytes appear to be  more consistent, characterized 
by an increase in expression for up to one hour post-exercise  (Gonzalez et al., 2014; Jajtner 
et al., 2014; Wells et al., 2016).  These latter results, though, did not examine the response 
of MAC1/CR3 on different monocyte subsets.  Limited research has suggested that 
classical monocytes may have a more robust response to exercise than the other monocyte 
subsets (Hong & Mills, 2008).   
As resistance exercise appears to elicit significant elevations in markers of 
oxidative stress (Merry & Ristow, 2015; Urso & Clarkson, 2003), antioxidant 
supplementation has been examined as a potential countermeasure to reduce the oxidative 
response to resistance exercise (Bowtell, Sumners, Dyer, Fox, & Mileva, 2011; Jowko et 
al., 2011; Panza et al., 2008; Paulsen et al., 2014).  Specifically, polyphenol 
supplementation has been demonstrated to reduce force deficits and markers of muscle 
damage in response to resistance exercise (Bowtell et al., 2011; Jowko et al., 2011; Panza 
et al., 2008) while others have demonstrated equivocal results (Paulsen et al., 2014).  
Furthermore, the cytokine/chemokine response following endurance exercise and vitamin 
A, C and E supplementation has demonstrated a blunted response of the pro-inflammatory 
cytokines IL-1β, IL-6 and TNF-α (Vassilakopoulos et al., 2003).  However, the benefits of 
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polyphenol supplementation in conjunction with eccentric exercise have been ambiguous 
(Herrlinger, Chirouzes, & Ceddia, 2015; Kerksick, Kreider, & Willoughby, 2010; O'Fallon 
et al., 2012).  Decreases in circulating neutrophil concentrations have been observed 48 
hours following eccentric exercise in conjunction with epigallocatechin gallate (EGCG) 
supplementation (Kerksick et al., 2010), however, the fate of these cells are unknown.  As 
polyphenol incubation results in reduced expression of adhesion molecules on neutrophils 
and monocytes, along with limited chemotaxis in vitro (Graff & Jutila, 2007; Kawai et al., 
2004; Takano, Nakaima, Nitta, Shibata, & Nakagawa, 2004) decreased neutrophil 
concentrations following exercise is not likely explained by increased infiltration.  To the 
best of our knowledge, the specific response of neutrophils and monocyte activation 
following polyphenol supplementation and resistance exercise is not well understood. 
Therefore, the primary purpose of this investigation was to examine the response 
of neutrophils and monocyte subtype proportion and activation to an acute bout of 
resistance exercise following 28-days of polyphenol supplementation.  Furthermore, a 
secondary purpose of this study was to investigate the impact of polyphenol 
supplementation on leukocyte recruitment, behavior, and activation as well as functional 
recovery in response to resistance exercise. 
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CHAPTER 2: REVIEW OF LITERATURE 
 
The immune system is composed to two primary arms; the adaptive immune system (or 
specific immunity) and the innate immune system.  Both arms function to maintain the 
health and integrity of the individual, yet have distinct responsibilities (Parkin & Cohen, 
2001).  While adaptive immunity can be characterized as a small, but specific response, 
requiring prior sensitization to the pathogen, innate immunity is characterized by a 
profound, non-specific response that becomes prominent upon the first encounter with the 
pathogen (Parkin & Cohen, 2001).  While both adaptive and innate immunity are active 
during and after exercise, the innate immune system plays a primary role in recovery from 
muscle damaging exercise. 
 Exercise resulting in muscle damage will initiate an inflammatory cascade that 
recruits immune cells, primarily neutrophils and monocytes, to the site of damage through 
the process of chemotaxis (Calle & Fernandez, 2010; Freidenreich & Volek, 2012).  When 
cells arrive at the site of damage they begin the process of diapedesis, and extravasation 
(Ley, Laudanna, Cybulsky, & Nourshargh, 2007), of which the β2 integrin macrophage-1 
antigen (MAC-1), also known as complement receptor-3 (CR3), plays a major role (Ehlers, 
2000; Ley et al., 2007; Tan, 2012).  Once at the site of tissue injury, immune cells complete 




Cytokine Signaling of Immune Cells 
 For the purposes of this review, a brief overview of cytokine function and 
classification will be given; however, the function of specific cytokines within the immune 
response to resistance exercise will be discussed in the later sections.  Cytokines are small 
proteins that are responsible for communication between immune cells (Nicod, 1993).  
Cytokines are also produced by a variety of cells, including leukocytes and skeletal muscle 
cells during and following exercise (Calle & Fernandez, 2010).  As cytokines are signaling 
molecules, they are classified based on the type of response they propagate, either pro-
inflammatory or anti-inflammatory (Pedersen, 2000).  Furthermore, cytokines can be 
broken into subsets based on their structure, and/or function.  Although there is some 
overlap between the classifications, the most notable cytokine subsets are interleukins (e.g. 
IL-1β, IL-6) and chemokines (Nicod, 1993).  Briefly, interleukin (“inter” – between; 
“leukin” – leukocyte) is an umbrella term to classify signaling molecules that mediate 
communication between leukocytes  (Nicod, 1993).   
 Chemokines serve as chemotactic agents, attracting leukocytes to the site of 
damage (Nicod, 1993).  Furthermore, chemokines are classified into four main subsets 
based on their protein structure, namely, the position of the first two cysteine molecules 
near the N-terminus (Rollins, 1997).  The three most common chemokine subsets within 
the immune response to resistance exercise are the CC (β-chemokines), CXC (α-
chemokines), and the CX3C chemokines (Nicod, 1993; Rollins, 1997).  Briefly, a CC 
chemokine positions two cysteine molecules adjacent to one another, while 1 or 3 
additional amino acids are positioned between the first and second cysteines of CXC or 
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CX3C chemokines, respectively (Rollins, 1997).  Therefore, the nomenclature for 
chemokines is based on the structure at the N-terminus, followed by the receptor or ligand 
number.  For instance, the chemokine CCL2 (also referred to as MCP-1) is ligand 2 of the 
CC chemokine family, while CX3CR1 is receptor 1 of the CX3C chemokine family. 
 
Immune cells Involved in the Inflammatory Response 
 Leukocytes are the cells that make up the immune system, and are classified into 
three major populations: lymphocytes, monocytes, and granulocytes.  Lymphocytes are 
sub-divided into T-, B- and natural killer (NK) cells, which collectively make up 
approximately 25% of total leukocytes in healthy individuals (Roussel, Benard, Ly-
Sunnaram, & Fest, 2010).  Monocytes make up 5-10% of total leukocytes in healthy 
populations, and give rise to dendritic cells (DC) (Roussel et al., 2010; Ziegler-Heitbrock 
et al., 2010).  Granulocytes are further divided into three cell types: neutrophils, basophils 
and eosinophils (Roussel et al., 2010).  In healthy individuals, neutrophils make up 50-70% 
of the total leukocyte population, while eosinophils and basophils make up approximately 
1-5% and <1%, respectively (Roussel et al., 2010).  In general, lymphocytes, namely T- 
and B- cells make up the adaptive immune system, while monocytes, granulocytes and NK 
cells make up the innate immune system (Parkin & Cohen, 2001). 
Development of leukocytes derive from hematopoietic stem cells (HSC), while 
lymphocytes develop through a common lymphoid progenitor (CLP), and the lymphoid 
pathway (Akashi, Traver, Miyamoto, & Weissman, 2000).  Monocytes and granulocytes 
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develop through the myeloid pathway, with a common myeloid progenitor (CMP), and a 
granulocyte/macrophage precursor (GMP) (Akashi et al., 2000; Summers et al., 2010).  
Following differentiation to the GMP, granulocytes and monocytes are developed by 
separate pathways.  Granulocytes continue to develop through granulocytic progenitor 
cells in the mitotic pool before developing into mature immune cells in the post-mitotic 
pool (Summers et al., 2010).  Within the bone marrow, monocytes continue to mature into 
macrophage/DC precursors followed by the commited monocyte progenitor (cMoP), and 
then develop into monocytes (Mitchell, Roediger, & Weninger, 2014). 
 
Granulocytes 
 Granulocytes are broken into three distinct cell types: neutrophils, basophils and 
eosinophils.  Neutrophils are the most numerous leukocyte, and within the context of 
muscle damage, are the most active granulocyte (Kolaczkowska & Kubes, 2013; Tidball, 
2005).  Mobilization of neutrophils from the bone marrow is stimulated by granulocyte 
colony stimulating factor (G-CSF) (Sadik, Kim, & Luster, 2011; Semerad, Liu, Gregory, 
Stumpf, & Link, 2002), while recruitment to damaged tissue is mediated by interactions 
with endothelial cells and specific cytokines (Kolaczkowska & Kubes, 2013; Ribeiro, 
Flores, Cunha, & Ferreira, 1991).  The cell surface receptors on neutrophils responsible for 
the cytokine-mediated recruitment are the CXC chemokine receptors 1 and 2 (CXCR1 and 
CXCR2) (Futosi, Fodor, & Mocsai, 2013; Hammond et al., 1995), which bind interleukin-
8 (IL-8; CXCL8), a potent chemoattractant of neutrophils (Ribeiro et al., 1991; Sadik et 
al., 2011).  Furthermore, recruitment of neutrophils by endothelial interaction is mediated 
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by adhesion receptors (Kolaczkowska & Kubes, 2013).  Neutrophils express several 
adhesion receptors, including L-selectin (CD62L), P-selectin glycoprotein ligand-1 
(PSGL-1), lymphocyte function-associate antigen 1 (LFA-1) and MAC1/CR3 (Futosi et 
al., 2013).  Each of these adhesion molecules perform prominent roles in the leukocyte 
adhesion cascade, which will be discussed in more detail later (Kolaczkowska & Kubes, 
2013; Ley et al., 2007).   
Following recruitment, neutrophils are the first cells to arrive at the site of 
inflammation following a bout of resistance exercise (Tidball & Villalta, 2010).  Within 
damaged tissue, neutrophils exhibit a multitude of functions, including phagocytosis, 
degranulation, and the release of neutrophil extracellular traps (NETs) (Kolaczkowska & 
Kubes, 2013).  The phagocytic response of the neutrophil is represented by the expression 
of phagocytic receptors, namely the Fc receptors cluster of differentiation- (CD) 64 and 
CD16, as well as  complement receptors on the cell surface (Dale, Boxer, & Liles, 2008; 
Futosi et al., 2013).  Briefly, during phagocytosis, the neutrophil recognizes opsonized 
debris, engulfs and then sequesters the debris into a phagosome (Dale et al., 2008; 
Kolaczkowska & Kubes, 2013).  Once the cellular debris is isolated, granules within the 
cytosol of the neutrophil will fuse to the phagosome, releasing enzymes to degrade the 
debris (Kolaczkowska & Kubes, 2013; Nguyen & Tidball, 2003b; Tidball, 2005). 
Myeloperoxidase (MPO), released from the primary granules, and nicotinamide 
adenine dinucleotide phosphate-oxidase (NADPH oxidase) are two important enzymes 
contained within neutrophils (Kolaczkowska & Kubes, 2013; Tidball, 2005).  During 
phagocytosis, as granules fuse to the phagosome, they also fuse to the cell membrane, and 
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release their contents into the phagosome, or extracellular space (Kolaczkowska & Kubes, 
2013; Nguyen & Tidball, 2003b; Tidball, 2005).  Once the enzymes are released, a 
cytotoxic environment is promoted in the phagosome and extracellular space through a 
specific pathway depicted in Figure 1 (Nguyen & Tidball, 2003b; Tidball, 2005).  Briefly, 
neutrophils consume oxygen that reacts with NADPH oxidase to produce superoxide 
(Hampton, Kettle, & Winterbourn, 1998).  Superoxide can be converted to hydrogen 
peroxide, by superoxide dismutase, which in turn is converted to hypochlorous acid by 
MPO, prompting cytolytic effects (Hampton et al., 1998; Kolaczkowska & Kubes, 2013; 
Tidball, 2005) (Figure 1). 
 
Figure 1: Secondary Damage by Neutrophils.   
Nicotinamide adenine dinucleotide phosphate-oxidase (NADPH oxidase) serves as 
the precursor to superoxide.  Superoxide dismutase (SOD) served as an 
intermediary, catalyze the conversion to hydrogen peroxide (H2O2).  
Myeloperoxidase catalyzes the reaction to hypochlorous acid (HOCl), which will 
induce skeletal muscle damage. 




The cytotoxic environment produced will prompt additional injury to the skeletal 
muscle, a process known as secondary damage (Nguyen & Tidball, 2003b; Pizza et al., 
2005; Tidball, 2005).  This secondary damage caused by neutrophils is enhanced later in 
recovery, through synergistic action with macrophages (Nguyen & Tidball, 2003a).  
Nonetheless, researchers have demonstrated that neutrophil mediated secondary damage is 
not necessary to maintain myofibril recovery, or macrophage populations in the murine 
model (Nguyen & Tidball, 2003b; Pizza et al., 2005).  However, others argue that 
neutrophils may provide protective effects to skeletal muscle, despite promoting secondary 
damage (Lockhart & Brooks, 2008; Teixeira et al., 2003; Tidball, 2005).  In the human 
model, neutrophil-mediated secondary damage has been suggested to enhance recruitment 
of circulating monocytes (Soehnlein, Lindbom, & Weber, 2009).  Furthermore, MPO 
appears to enhance the phagocytic activity of CD68, a significant receptor of macrophages, 
leading to enhanced macrophage activation (Kolaczkowska & Kubes, 2013; Tidball & 
Villalta, 2010; Zouaoui Boudjeltia et al., 2004).  Therefore, it appears that neutrophils may 
not be necessary for recovery, however, may aid in the recovery process.   
 
Monocytes 
For nearly 25 years, monocytes, which make up approximately 5-10% of the total 
circulating leukocyte population (Booth et al., 2010; Hong & Mills, 2008), have been sub-
divided into two primary categories, classical and nonclassical monocytes (Wong et al., 
2012; Ziegler-Heitbrock et al., 2010; Ziegler-Heitbrock & Hofer, 2013).  Recent work, 
however has demonstrated a differential function of the lesser, nonclassical monocyte 
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(Cros et al., 2010; Wong et al., 2011; Zawada et al., 2011).  This led to further refinement 
of monocytes, and the newly accepted population of intermediate monocytes (Ziegler-
Heitbrock et al., 2010).  These monocyte subsets have been widely identified via flow 
cytometry based on their differential expression of the lipopolysaccharide (LPS) receptor, 
CD14 and the FcγRIIIa receptor, CD16, as seen in Figure 2 (Wong et al., 2012; Ziegler-
Heitbrock et al., 2010).  Wong and colleagues (2012), among others (Ziegler-Heitbrock et 
al., 2010) have previously defined classical monocytes as CD14++/CD16-, intermediate 
monocytes as CD14++/CD16+ and nonclassical monocytes as CD14+/CD16++.  While 
these subsets have at times been referred to as inflammatory and anti-inflammatory, 
Ziegler-Heitbrock and colleagues (2010) recommend caution with these labels.  They argue 
that these terms have been interchanged based on the species (murine vs human), and may 
lead to an oversight of important roles for each population (Ziegler-Heitbrock et al., 2010).  
Therefore, for the purposes of this review, monocytes will be subdivided into three 
categories: classical monocytes (CD14++/CD16-), intermediate monocytes 
(CD14++/CD14+) and nonclassical monocytes (CD14+/CD16+).  Due to the recent 
discrimination between nonclassical and intermediate monocytes, there are limitations on 
the studies completed prior to this point.  In order to examine these studies, discussion of 




Figure 2: Fluorescent Characteristics of Monocyte Subsets.  
Monocytes were analyzed for their differential expression of cluster of 
differentiation (CD)-14 and CD16.  Monocytes were classified as Classical (Clas), 




Classical monocytes remain in circulation for a few days after release from the bone 
marrow (Wong et al., 2011; Ziegler-Heitbrock et al., 2010; Ziegler-Heitbrock & Hofer, 
2013).  It has been suggested that a developmental relationship may exist between classical 
monocytes with intermediate and nonclassical monocytes (Ancuta et al., 2009; Ziegler-
Heitbrock et al., 2010).  While there is compelling data demonstrating modulation of key 
receptors on monocytes in vitro (Ramos et al., 2010), formal demonstration of a 
progressive relationship between monocytes has yet to be provided in humans (Wong et 
al., 2012; Ziegler-Heitbrock et al., 2010).  Classical monocytes make up the majority of 
the monocyte population, ranging between 80 to 90% of the total monocyte population at 
rest in healthy individuals (Wong et al., 2011; Ziegler-Heitbrock et al., 2010; Ziegler-
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Heitbrock & Hofer, 2013).  However, this can be greatly altered in several clinical and non-
clinical conditions (Booth et al., 2010; Hristov & Weber, 2011; Rossol, Kraus, Pierer, 
Baerwald, & Wagner, 2012; Simpson et al., 2009; Tapp et al., 2012). 
In response to LPS-mediated activation, classical monocytes secrete a variety of 
chemotactic cytokines, including G-CSF, IL-8, CCL3, CCL5, and MCP-1 in addition to 
IL-6 and IL-10 at high levels (Cros et al., 2010; Wong et al., 2011; Wong et al., 2012).  
LPS-stimulation also results in pro-inflammatory cytokine (IL-1β and TNFα) production 
at moderate levels in classical monocytes (Cros et al., 2010; Wong et al., 2011).  
Furthermore, classical monocytes demonstrate a high degree of reactive oxygen species 
(ROS) production in response to LPS stimulation, and the highest phagocytic ability of the 
three monocyte subsets (Cros et al., 2010; Zawada et al., 2011). 
While the secretion of cytokines may explain the potential effects of classical 
monocytes on the overall milieu of the adjacent area, examination of receptor expression 
on classical monocytes demonstrates the phagocytic role of this subset.  Classical 
monocytes express greater levels of CD36 and CD64, which serve as a scavenging receptor 
and receptors that initiate phagocytosis, respectively (Cros et al., 2010; Wong et al., 2011; 
Zawada et al., 2011).  Classical monocytes also express the greatest proportion of the CCR2 
(receptor for MCP-1) and CXCR1 and CXCR2 (receptors for IL-8) when compared to 
intermediate and nonclassical monocytes (Cros et al., 2010; Wong et al., 2011).  Despite 
the increased expression of CXCR1 and CXCR2 on classical monocytes, the primary 
chemotactic response of this specific subset is mediated by the MCP-1/CCR2 interaction 
(Leonard & Yoshimura, 1990; Wong et al., 2012; Yadav et al., 2010; Yang et al., 2014).  
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Interestingly, expression of CX3CR1 is greatly reduced on classical monocytes; a defining 
characteristic of classical versus intermediate and nonclassical monocytes (Cros et al., 
2010; Wong et al., 2011).  Finally, classical monocytes are characterized by high 
expression of L-selectin (CD62L) and CD11b, which are necessary components of the 
adhesion cascade, discussed later (Cros et al., 2010; Wong et al., 2011; Zawada et al., 
2011).  Taken together, evidence demonstrates the ability of the classical monocyte to 
migrate to the site of tissue damage, cross the endothelial wall, and scavenge/phagocytose 
damaged tissue.   
 
Intermediate Monocytes 
Intermediate monocytes are the newest subset to be identified, and were formally 
labeled in 2010 with the consortium statement put forward by the International Union of 
Immunological Societies and the World Health Organization (Ziegler-Heitbrock et al., 
2010).  As stated previously, intermediate monocytes appear to have a developmental 
relationship between classical and nonclassical (Wong et al., 2012; Ziegler-Heitbrock et 
al., 2010), evidenced by the intermediate expression of several receptors and cytokine 
production.  Typically, intermediate monocytes make up 5-10% of the total circulating 
monocytes (Wong et al., 2012; Ziegler-Heitbrock et al., 2010; Ziegler-Heitbrock & Hofer, 
2013), although this can vary greatly with clinical conditions (Hristov & Weber, 2011; 
Rossol et al., 2012; Tapp et al., 2012).   
Intermediate monocyte display elevated expression of CD11b, a characteristic they 
share with classical monocytes (Cros et al., 2010; Wong et al., 2012; Zawada et al., 2011).  
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However, intermediate monocytes also have positive expression of CX3CR1 (receptor for 
CX3CL1) and lack L-Selectin (CD62L),  characteristics they share with nonclassical 
monocytes (Cros et al., 2010; Wong et al., 2011; Zawada et al., 2011).  While intermediate 
monocytes have a high capacity for phagocytosis (Cros et al., 2010; Zawada et al., 2011), 
ROS production from this subset is controversial.  Cros and colleagues (2010) reported 
minimal ROS production, while Zawada, et al. (2011) reported the greatest ROS 
production from intermediate monocytes.  Zawada and colleagues (2011) attribute this 
difference to the discrepancies between the sampling techniques used.  Intermediate 
monocytes also display an inflammatory function, in addition to functioning as an antigen 
presenting cell, while also demonstrating an ability to cross the endothelium into damaged 
tissue (Yang et al., 2014).   
 The inflammatory nature of the intermediate subset is tied to the pro-inflammatory 
milieu it promotes.  Intermediate monocytes secrete greater amounts of IL-6, and IL-1β, 
than any other subset, as well as a moderate amount of IL-8 and IL-10 following LPS 
stimulation (Cros et al., 2010; Rossol et al., 2012; Wong et al., 2011).  Additionally, TNF-
α likely adds to the pro-inflammatory milieu.  In response to LPS, TNF-α production has 
been shown to both increase (Cros et al., 2010; Rossol et al., 2012) and remain unchanged 
(Wong et al., 2011), which was suggested to be the result of different clones used to identify 
CD14 (LPS receptor) (Wong et al., 2011).  The use of the M5E2 clone for CD14 (as used 
by Cros and colleagues (2010)) has demonstrated deleterious effects on the LPS signaling 
(Power et al., 2004).  However, with the elevated expression of CD14 on intermediate 
monocytes, in conjunction with the positive LPS-mediated response (Cros et al., 2010), it 
is unlikely the M5E2 clone had an impact on the results.  Furthermore, Rossol and 
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colleagues (2012) demonstrated similar TNF-α production following LPS stimulation, 
though, the in vitro nature of these analyses may impact the findings (Wong et al., 2012).  
Despite this, in response to LPS signaling it appears intermediate monocytes produce 
multiple pro-inflammatory cytokines, likely leading to their pro-inflammatory nature. 
The antigen presenting capabilities of intermediate monocytes appear to be related 
to the increased expression of major histocompatibility (MHC) proteins human leukocyte 
antigen (HLA)-ABC and HLA-DR relative to classical and nonclassical monocytes 
(Rossol et al., 2012; Wong et al., 2011; Zawada et al., 2011).  As these MHC molecules 
function with T lymphocytes, they are capable of recruiting T cells to the injured area for 
assistance in the healing process (Grage-Griebenow et al., 2001; Wong et al., 2012).  
Therefore, modulation of the number of intermediate monocytes in circulation may 
potentiate or mitigate the T cell response.   
 
Nonclassical monocytes 
 Nonclassical monocytes are considered the most developed of the three monocyte 
subsets (Wong et al., 2012; Ziegler-Heitbrock & Hofer, 2013).  Nonclassical monocytes 
make up approximately 5-10% of total monocytes, and are considered the “patrolling” 
subset, residing primarily in the marginal pool (Cros et al., 2010).  Other than the general 
characteristic of CD14 and CD16, the nonclassical subset is phenotypically characterized 
by a relatively high expression of CX3CR1, with relatively low expression of CCR2, 
CCR5, CD11b and CD36 (Cros et al., 2010; Wong et al., 2011; Zawada et al., 2011).  
CX3CR1, the primary receptor for CX3CL1 (Ancuta et al., 2003), serves as the primary 
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receptor involved in the extravasation process for nonclassical monocytes (Cros et al., 
2010; Yang et al., 2014).  In addition, due to the patrolling nature of nonclassical 
monocytes, the phagocytic ability and ROS production of these monocytes have been 
reported to be lower than the other monocyte subsets (Cros et al., 2010; Zawada et al., 
2011).   
 Cytokine production of nonclassical monocytes is rather controversial.  In response 
to LPS, Wong et al. (2011) reported elevated production of pro-inflammatory cytokines 
(IL-1β, IL-6 and TNF-α).  However, other investigations have demonstrated production of 
only IL-1ra, with minimal production of pro-inflammatory cytokines (Cros et al., 2010; 
Rossol et al., 2012).  Additionally, as Cros and colleagues (2010) identified monocytes 
with the M5E2 clone for CD14, the limited pro-inflammatory cytokine production 
observed (Cros et al., 2010), may be a function of the deleterious effects of the M5E2 on 
LPS signaling (Power et al., 2004).  Unfortunately, the clone used by Rossol and colleagues 
(2012), was not reported, and therefore may have the same limitations as reported by Cros 
et al. (2010).  However, Rossol and colleagues (2012) did report minimal pro-inflammatory 
cytokine production following co-incubation with activated T-cells.  Therefore, it is unclear 
whether pro-inflammatory cytokine production is a prominent feature of nonclassical 
monocytes. 
 
Overview of the Monocyte Subsets 
 As stated previously, the relationship between the three monocyte subsets has been 
suggested to be of a developmental nature, originating from classical monocytes (Ancuta 
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et al., 2009; Ziegler-Heitbrock & Hofer, 2013).  This can be observed through the 
progression of receptor expression and cytokine production between the subsets depicted 
in Figure 3.  Evidence demonstrating the modulation of key receptors on monocytes, 
namely CX3CR1 and CD14 in response to specific cytokines has been presented 
previously (Ramos et al., 2010).  Specifically, Ramos and colleagues (2010) demonstrated 
that IL-10 maintained the already elevated expression of CX3CR1 on cultured monocytes, 
indicating a maintenance of the moderately matured state (intermediate monocyte).  
Furthermore, when monocytes were cultured with INF-γ, CX3CR1 expression was also 
maintained, however, a concomitant decrease in the expression of CD14 was demonstrated 
(Ramos et al., 2010).  This decrease in CD14 results in a phenotype characterized by low 
CD14, but high CX3CR1 expression, similar to nonclassical monocytes (Wong et al., 
2012).  Together, the results of Ramos and colleagues (2010) show a potential maturing 
effect of the monocyte lineage under inflammatory conditions that present INF-γ.   
In summary, the phagocytic classical monocytes express high levels of receptors 
CCR2, CCR5, CD11b and CD62L, in conjunction with low expression of CX3CR1.  As 
classical monocytes mature into the inflammatory intermediate subset, they lose CD62L 
expression, begin to lose the expression of CCR2, however, gain the expression of 
CX3CR1 and HLA-DR.  As these cells continue to develop into patrolling nonclassical 
monocytes, the expression of CCR5, CD11b and HLA-DR is reduced, while the expression 
of CX3CR1 is maintained (Cros et al., 2010; Wong et al., 2011; Zawada et al., 2011).  A 
depiction of the differential expression of receptors and cytokine production is presented 





Figure 3: Phenotypic Differences of Monocyte Subsets.   
Receptors and cytokines displayed in red, orange and white are highly, moderately 
or minimally expressed/produced, respectively.  Production of cytokines expressed 
in grey are contested within literature. 
Cytokines displayed: Monocyte chemoattractant protein-1 (MCP-1), Tumor 
necrosis factor-α (TNF-α), and Interleukins (IL)- 1β, IL-6, IL-8 and IL-10. 
Receptors displayed: Cluster of differentiation (CD)-14 (LPS receptor), CD16 (Fc 
receptor FcγRIIIa), CD11b (α unit of MAC1), CD62L (L-selectin), CC chemokine 
receptors 2 and 5 (CCR2, CCR5), CX3C chemokine receptor 1 (CX3CR1), and 
Human Leukocyte Antigen (HLA)-DR 
 
Macrophages  
 Macrophages are differentiated from monocytes within tissue following 
transmigration (Yang et al., 2014).  Similar to monocytes, macrophages are heterogeneous 
and their functions are similarly varied (Novak & Koh, 2013; Pilling, Fan, Huang, Kaul, & 
Gomer, 2009).  Macrophages can be primarily separated into two categories, M1 and M2, 
and  the M2 macrophages can be further segregated into three subsets; M2a, M2b and M2c 
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(Novak & Koh, 2013).  These subsets, however, seem to be a function primarily of 
controlled environments within in vitro analysis, and do not always maintain these ridged 
phenotypes in vivo (Mosser & Edwards, 2008; Novak & Koh, 2013).  The in vitro model, 
however, may be helpful in understanding the myriad of roles macrophages participate in 
during skeletal muscle damage and recovery. 
 
Inflammatory (M1) Macrophages 
 Inflammatory macrophages (M1) are the first cells of the mononuclear phagocyte 
system observed in skeletal muscle tissue following damage (Novak & Koh, 2013; Tidball 
& Villalta, 2010).  This typically occurs between 1 - 3 days following damage and is 
preceded by neutrophil invasion, and characterized by a large inflammatory response 
(Tidball, 2005; Tidball & Villalta, 2010).  Furthermore, the macrophage response seems to 
be required for complete skeletal muscle recovery following exercise induced muscle 
damage (Cheng, Nguyen, Fantuzzi, & Koh, 2008; Rigamonti et al., 2013; Tidball & 
Wehling-Henricks, 2007).   
M1 macrophages originate from classical monocytes following migration to the 
tissue, through a process known as classical activation (Yang et al., 2014). Classical 
activation is primarily mediated by specific inflammatory cytokines, namely INF-γ, 
although TNF-α has also been implicated in this process (Mosser & Edwards, 2008; Novak 
& Koh, 2013).  M1 macrophages are known to express CD68 (Pilling et al., 2009), a 
receptor for oxidized low-density lipoprotein (oxLDL) (Tidball & Villalta, 2010; Van 
Velzen, Da Silva, Gordon, & Van Berkel, 1997).  CD68 will become more active with 
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increased MPO-mediated oxidation of LDL (Zouaoui Boudjeltia et al., 2004), which is 
released by neutrophils prior to M1 invasion (Kolaczkowska & Kubes, 2013).  This leads 
to the binding of CD68, contributing to the activation of the M1 macrophage (Tidball & 
Villalta, 2010) and underlining the importance of the neutrophil response to muscle 
damage.  M1 macrophages appear to exclusively express CD80 (Ambarus et al., 2012), 
however, do not express CD163 or CD206 (markers of M2 macrophages) (Novak & Koh, 
2013).   
Similar to neutrophils, M1 macrophages are known to contribute to secondary 
damage, and is amplified in the presence of neutrophils (Nguyen & Tidball, 2003a).  This 
effect is facilitated via a nitric oxide- (NO) mediated reaction through the production of 
inducible nitric oxide synthase (iNOS), further disrupting the integrity of the tissue 
(Nguyen & Tidball, 2003a).  Moreover, the secondary damage produced by iNOS appears 
to be required for complete recovery (Rigamonti et al., 2013).  M1 macrophages also aid 
with the proliferation of myogenic precursor cells (MPC), and are the primary source of 
intramuscular insulin-like growth factor-1 (IGF-1) during the early phase of recovery 
(Arnold et al., 2007; Song et al., 2000; Tidball & Welc, 2015; Tonkin et al., 2015).  
Additionally, M1 macrophages produce several pro-inflammatory cytokines, including IL-
1β, IL-6, IL-12, and TNF-α (Chazaud, 2014).  Furthermore, T-helper 1 (Th1) lymphocytes 
assist M1 macrophages by also secreting pro-inflammatory cytokines, including INF-γ 
(Mosser & Edwards, 2008).  The secretion of INF-γ from Th1 cells promotes classical 
activation, and allows for the maintenance of M1 macrophages within the damaged tissue 
(Mosser & Edwards, 2008).   
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In conjunction with Th1 cells, M1 macrophages maintain this inflammatory milieu 
throughout the early phase of recovery (Chazaud, 2014; Mosser & Edwards, 2008).  
However, as classically activated macrophages begin to phagocytize debris, they begin to 
polarize into a more anti-inflammatory phenotype (Arnold et al., 2007), a process that is 
aided by the T-helper-2 lymphocyte (Th2) response (Chazaud, 2014).  During this process, 
the immune cells begin to promote a cytokine milieu consisting primarily of IL-4, and IL-
13, prompting “alternative” macrophage activation (Mosser & Edwards, 2008). 
  
Anti-inflammatory (M2) Macrophages 
 Anti-inflammatory, or M2, macrophages are developed by phagocytosis or 
alternative activation (Arnold et al., 2007; Mosser & Edwards, 2008).  M2 macrophages 
are the predominant cell of the mononuclear phagocytic system during the late phase of 
inflammation, between 3 – 7 days following injury (Tidball & Villalta, 2010).  The 
polarization of M1 to M2 macrophages is typically mediated by phagocytosis or alternative 
activation (Arnold et al., 2007).  However, recent evidence from Tonkin and colleagues 
(2015) suggests that the IGF-1 produced by M1 macrophages may contribute as well.  
Development of M2 macrophages from nonclassical monocytes is mediated exclusively 
through the alternative pathway (Brigitte et al., 2010; Nahrendorf et al., 2007).  
Furthermore, the anti-inflammatory cytokines IL-4, IL-10 and IL-13 govern alternative 
activation (Arnold et al., 2007).  Prior to M2 development, nonclassical monocytes will 
cross the endothelium via interaction of the CX3CR1 on the immune cell and CX3CL1, 
which is bound to endothelial cells (Ancuta et al., 2003; Auffray et al., 2007).   
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Due to the heterogeneity of the M2 subset, and the plasticity of macrophages in 
general, it is difficult to identify a common receptor on all M2 phenotypes.  Moreover, 
macrophages are able to augment their phenotype and function based on the surrounding 
environment (Mosser & Edwards, 2008; Novak & Koh, 2013; Stout et al., 2005).  With 
this in mind, macrophages that are cultured in cytokines characteristic of alternative 
activation (IL-4 and IL-10) result in increased expression of CD163 and CD206 (Ambarus 
et al., 2012; Buechler et al., 2000).  M2 macrophages also promote an anti-inflammatory 
milieu characterized by increased production of IL-1 receptor antagonist (IL-1ra), IL-10, 
and transforming growth factor-β (TGF-β) (Ambarus et al., 2012; Chazaud, 2014; Song et 
al., 2000; Stout et al., 2005).  Furthermore, M2 macrophages display reduced expression 
of pro-inflammatory cytokines TNF-α and IL-1β (Chazaud, 2014; Song et al., 2000; Stout 
et al., 2005).   
During the late phase of recovery, M2 macrophages promote the differentiation of 
MPC into mature myotubes (Arnold et al., 2007; Martin & Lewis, 2012; Saclier et al., 
2013; Song et al., 2000).  M2 macrophages also produce fibrous tissue (Song et al., 2000), 
and continue to secrete IGF-1 within skeletal muscle (Tonkin et al., 2015).  Due to the anti-
inflammatory environment promoted by M2 macrophages, IGF-1 is suggested to stimulate 
the p70S6K signaling pathway (Tidball & Welc, 2015; Tonkin et al., 2015).  Taken together, 
M2 macrophages promote an anti-inflammatory environment that is characterized by 




Overview of M1/M2 Macrophages 
Macrophages that respond to tissue damage are most readily defined by their 
polarized moieties, M1 and M2.  In general, these polarization states are characterized by 
a pro-inflammatory M1 phenotype, that maintains an environment rich in the pro-
inflammatory cytokines INF-γ and TNF-α (Chazaud, 2014).  The M2 phenotype is 
characterized by the maintenance of an anti-inflammatory milieu, consisting of IL-4, IL-
10 and IL-13 (Gordon & Martinez, 2010).  Furthermore, the M1 polarization contributes 
to phagocytosis, and secondary damage (Tidball & Villalta, 2010), while also stimulating 
MPC proliferation (Arnold et al., 2007; Song et al., 2000).  The M2 polarization contributes 
to fiber regeneration, and the promotion of MPC differentiation (Arnold et al., 2007; 
Mosser & Edwards, 2008; Saclier et al., 2013).  Additionally, M1 and M2 macrophages 
provide the initial source of IGF-1 within skeletal muscle during recovery (Tonkin et al., 
2015).  Many investigations have also suggested that macrophages exhibit great plasticity, 
and caution against strict adherence to the M1/M2 characterization (Novak & Koh, 2013; 
Stout et al., 2005).   
 
Resident Macrophages 
 Resident macrophages were first identified in skeletal muscle in 1990 using specific 
labeling with ectodermal dysplasia antibodies- 1, 2 and 3 (ED1, ED2 and ED3) (Honda, 
Kimura, & Rostami, 1990).   These antibodies labeled both monocytes and macrophages 
(ED1), or were specific to macrophages (ED2 and ED3) (Dijkstra, Dopp, Joling, & Kraal, 
1985).  Honda and colleagues (1990) identified the presence of ED2 and ED3 macrophages 
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within the perimysium (Honda et al., 1990), while a follow-up study by McLellan (1993) 
determined that ED2 and ED3 macrophages did not participate in phagocytic activity 
(McLennan, 1993).  However, upon further examination it was determined that the animals 
used by McLellan (1993) were likely not sacrificed in a resting state, indicating potential 
for myeloid cellular invasion prior to analysis, and the results of this study should be 
interpreted with caution.  Subsequent examinations of the ED1, ED2 and ED3 phenotypes 
have identified close relationships between these antibodies, and receptors currently used 
to identify macrophages today, namely CD68, and CD163 (Damoiseaux et al., 1994; 
Pilling et al., 2009; Polfliet, Fabriek, Daniels, Dijkstra, & van den Berg, 2006). 
The findings of Honda and colleagues (1990) have subsequently been confirmed 
with specific phenotyping for myeloid cells (MAC1/CR3), and mononuclear cells (F4/80) 
(Pimorady-Esfahani, Grounds, & McMenamin, 1997).  Recently, Brigitte and colleagues 
(2010) demonstrated similar results with further discrimination against DC and classical 
monocytes.  Furthermore, they also demonstrated specific recruitment of monocytes and 
neutrophils from resident macrophages.  Briefly, following toxin (notexin) induced injury 
to skeletal muscle, or stimulation with TNF-α, resident macrophages selectively produce 
MCP-1 and cytokine-induced neutrophil chemoattractant (CXCL1) (Brigitte et al., 2010).  
Additionally, patrolling monocytes (nonclassical) have been demonstrated to migrate into 
tissue, and propagate the inflammatory response (Auffray et al., 2007).  Consequently, both 
resident macrophages and nonclassical monocytes appear to be involved with initiating the 
immune response to tissue damage. 
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Exercise itself, may also propagate the inflammatory response.  Exercise is known 
to induce increased mRNA expression of several chemokines in skeletal muscle, including 
those for neutrophil and monocyte recruitment in humans (Catoire, Mensink, Kalkhoven, 
Schrauwen, & Kersten, 2014; Della Gatta et al., 2014; Nieman et al., 2004; Stromberg et 
al., 2016).  While these investigations were unable to isolate the source of the mRNA 
expression, it is possible myeloid cells were responsible.  Evidence from a murine model 
demonstrated myeloid depletion resulting in a significantly reduced mRNA expression of 
pro-inflammatory cytokines (IL-6, TNF-α and IL-1β) post-exercise (Kawanishi, 
Mizokami, Niihara, Yada, & Suzuki, 2016).  Resident macrophages and monocytes appear 
to produce these pro-inflammatory cytokines in the recovery period following exercise.  
Consequently, these cells may be the primary cells responsible for the initiation of the 
immune response to exercise induced muscle damage.  
 
Endothelial Cells and Leukocyte Recruitment 
 While endothelial cells are not direct members of the innate immune system, they 
do have a pivotal role in the development of the immune response (Ley et al., 2007).  
Endothelial cells express specific adhesion receptors, namely P- and E-selectin 
(Kolaczkowska & Kubes, 2013; Ley et al., 2007), which when activated will bind PSGL-
1, a prominent ligand of neutrophils (Futosi et al., 2013).  Furthermore, once activated, 
endothelial cells will also express CX3CL1, a chemoattractant to nonclassical monocytes 
and T-cells (Ancuta et al., 2004; Ancuta et al., 2003; Ludwig, Berkhout, Moores, Groot, & 
Chapman, 2002).  As these adhesion receptors and chemoattractants are expressed, 
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immune cells will bind and initiate transendothelial migration.  Activation of endothelial 
cells is accomplished through various pro-inflammatory cytokines, such as TNF-α, INF-γ 
and IL-1β (Ludwig et al., 2002; Rollins, Yoshimura, Leonard, & Pober, 1990).  Moreover, 
resistance exercise upregulates the production of IL-1β and TNF-α within skeletal muscle 
(Buford, Cooke, & Willoughby, 2009; Nieman et al., 2004), likely sourced by resident 
macrophages (Kawanishi et al., 2016).  Therefore, resistance exercise prompts the 
production of pro-inflammatory cytokines that are responsible for the activation of 
endothelial cells, indirectly contributing to the migration of leukocytes.   
 
Immune Cell Response to Exercise-Induced Muscle Damage 
 It is well understood that resistance exercise may result in muscle damage resulting 
from metabolic, oxidative stress, as well as mechanical stresses (Brancaccio, Lippi, & 
Maffulli, 2010; Calle & Fernandez, 2010; Clarkson & Hubal, 2002; Clarkson, Kearns, 
Rouzier, Rubin, & Thompson, 2006; Finaud, Lac, & Filaire, 2006).  Myofibrillar damage 
produced in skeletal muscle following damaging exercise is characterized by leakage of 
various biomarkers from the sarcolemma (Brancaccio et al., 2010; Clarkson & Hubal, 
2002; Clarkson et al., 2006), reduced voluntary contraction (Byrne & Eston, 2002; Paulsen 
et al., 2005) and muscle soreness (Cheung, Hume, & Maxwell, 2003; Jajtner et al., 2015).  
These indicators of exercise induced muscle damage are also associated with a pro-
inflammatory cytokine response (Buford et al., 2009; Della Gatta et al., 2014; Nieman et 
al., 2004), resulting in significant leukocyte mobilization (Paulsen et al., 2005; Ramel, 
Wagner, & Elmadfa, 2003; Saxton et al., 2003; Simonson & Jackson, 2004).  Resistance 
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exercise appears to indirectly contribute to the recruitment of leukocytes by activating 
resident tissue macrophages (Brigitte et al., 2010; Buford et al., 2009; Kawanishi et al., 
2016), which in turn, release potent chemoattractants and cytokines that stimulate 
endothelial cell-mediated migration (Brigitte et al., 2010; Buford et al., 2009; Imai et al., 
1997; Kawanishi et al., 2016; Szmitko et al., 2003).  
An overview of the immune cell cascade during recovery from skeletal muscle 
damage is depicted in Figure 4.  Briefly, resident macrophages and nonclassical monocytes 
are activated, stimulating a response by endothelial cells, neutrophils and monocytes, 
resulting in their infiltration of the damaged tissue (Brigitte et al., 2010; Kawanishi et al., 
2016; Ludwig et al., 2002; Rollins et al., 1990).  Neutrophils are the first to arrive at the 
site of damage, propagating inflammation, while also clearing debris (Kolaczkowska & 
Kubes, 2013).  Subsequently, classical monocytes infiltrate the tissue and develop into M1 
macrophages, proliferating inflammation by essentially “priming” the tissue for recovery 
(Tidball & Villalta, 2010).  Simultaneously, Th1 cells are attracted to the site of damage, 
possibly through antigen presentation performed by intermediate monocytes, and 
contribute to the inflammatory milieu created during the early phase of recovery (Grage-
Griebenow et al., 2001; Wong et al., 2012).  As M1 macrophages phagocytize debris within 
the damaged tissue, polarization to an M2 phenotype occurs, establishing a 
microenvironment more conducive to repair and healing (Arnold et al., 2007; Tidball & 
Villalta, 2010).  Concurrently, Th1 cells are replaced with Th2 cells, which support the 
cytokine milieu associated with M2 macrophages during the late phase of skeletal muscle 
recovery (Mosser & Edwards, 2008).  Therefore, during the preliminary (neutrophil) and 
early (M1 macrophage) phases of recovery, a pro-inflammatory microenvironment is 
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supported, before yielding to an anti-inflammatory milieu during the late phase of recovery 
(M2 macrophages) (Tidball & Villalta, 2010).   
 
Figure 4: Overview of the Innate Immune Cells involved in Skeletal Muscle 
Damage.   
Resident macrophages and nonclassical monocytes induce a response to skeletal 
muscle damage.  Neutrophils are the first myeloid cell to enter the tissue (PMN 
Infiltration).  Within tissue, neutrophils promote phagocytosis, and release 
myeloperoxidase (MPO), which contributes to secondary damage.  Classical 
monocytes enter the tissue and classically activate into M1 macrophages.  M1 
macrophages also contribute to secondary damage, as well as phagocytose 
apoptotic neutrophils and debris prior to polarizing into M2 macrophages.  M2 
macrophages support the cessation of inflammation and the recovery of the tissue.  
T-helper-1 (Th1) and -2 (Th2) cells aid with maintaining the pro- and anti- 
inflammatory milieu, respectively. 
 
Circulating Neutrophil Response to Exercise 
It is well established that the number of neutrophils in circulation increase 
following exercise (Miles et al., 1998; Nieman et al., 2004; J. M. Peake, K. Suzuki, G. 
31 
 
Wilson, et al., 2005; Radom-Aizik, Zaldivar, Leu, Galassetti, & Cooper, 2008; Ramel, 
Wagner, & Elmadfa, 2004).  Limited studies involving resistance exercise have 
demonstrated an increase in neutrophil numbers immediately following exercise (Miles et 
al., 1998; Nieman et al., 2004; Ramel et al., 2004; Simonson & Jackson, 2004).  
Furthermore, elevations in neutrophil number are maintained for up to two hours post-
exercise (Nieman et al., 1995; Ramel et al., 2003).  However, data regarding neutrophil 
population 24 hours or more post-exercise in healthy participants appears to be lacking. 
While examination of the neutrophil response to resistance exercise is limited, 
examination of other modes of exercise may provide additional insight to the overall 
neutrophil response.  As resistance exercise may elicit muscle damage (Brancaccio et al., 
2010; Clarkson & Hubal, 2002), examination of the neutrophil response to exercise 
designed to elicit muscle damage may provide evidence for a time course of neutrophil 
recovery (Peake, Nosaka, & Suzuki, 2005).  Peak neutrophil counts resulting from 
eccentrically induced muscle damage have been reported at 4- (Saxton et al., 2003), 6- 
(Malm, Lenkei, & Sjodin, 1999; Malm et al., 2000; Paulsen et al., 2005), and 12-hours 
(Pizza et al., 1996) post-exercise.  Several investigators have further reported neutrophil 
counts return to resting levels by 24-hrs following exercise induced muscle damage (Malm 
et al., 1999; Paulsen et al., 2005; Saxton et al., 2003), while others, have reported a rebound 
effect of total neutrophil count between 48H-96H post-exercise (Pizza et al., 1996).  It has 
also been suggested that the addition of muscle biopsies to an investigation may affect the 
recruitment of neutrophils, and subsequently influence the rebound effect (Malm et al., 
2000).  Based upon available evidence it appears that the neutrophil population will expand 
for up to two hours following resistance exercise.  However, if the intensity is sufficient to 
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elicit muscle damage, this neutrophilia may continue for up to 12 hours before returning to 
resting levels.  While it is unclear whether a typical bout of resistance exercise will respond 
in similar fashion to exercise designed to elicit muscle damage, there is evidence to support 
a rebound effect 48 hours following muscle damage. 
 
Circulating Monocyte and Monocyte Subset Response to Exercise 
Total monocytes concentrations have been reported to increase in response to both 
aerobic (Booth et al., 2010; Hong & Mills, 2008; Shantsila et al., 2012) and resistance 
exercise (Miles et al., 1998; Nieman et al., 2004; Simonson & Jackson, 2004).  Typically, 
total monocyte count is elevated, peaking between immediately post-exercise and two 
hours post-exercise (Ramel et al., 2003).  It appears that both exercise intensity and rest 
intervals may influence when this peak response occurs, with submaximal resistance 
exercise prompting a delayed monocytosis (Mayhew, Thyfault, & Koch, 2005; Ramel et 
al., 2003).   
Investigations of monocyte subsets and their response to exercise have been 
limited.  This is likely due to the recent formal redefinition of monocytes to include a third 
subset six years ago (Ziegler-Heitbrock et al., 2010).  To our knowledge, following this 
redefinition only seven investigations have been published discussing shifts in monocyte 
subsets following exercise, with one additional investigation conducted in 2009 (Tables 1 
and 2).  Briefly, these investigations primarily examined cardiorespiratory exercise 
challenges, and typically assess the monocyte response only once, immediately following 
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exercise.  Additionally, some of these studies examined the changes of monocyte subsets 
following exercise in clinical populations (Dimitrov et al., 2013; Dungey, Bishop, Young, 





Table 1. Monocyte Subset Modulations in response to Exercise in Healthy Populations.   
Data reported as Mean (SD) 
* Reported significant difference from pre; ~ no SD reported; Italics: Absolute Counts (109 x L-1). 
Classical monocytes (CLAS), Intermediate monocytes (INTER), and nonclassical monocytes (NC) 




 Pre Exercise Post Exercise 1H Post Exercise 






45 min Run at 
75% VO2 Max 































































10 x 2min 
(1min Rest) 
~82% of max 
Cycle 
Ergometer 













 65.7 (7.7) 7.6 (2.9) 6.8 (3.9) 53.0 (8.6)* 15.9 (6.7)* 14.1 (6.3)* N/A N/A N/A 
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Table 2. Monocyte Subset Modulations in response to Exercise in Clinical Populations. 
Data reported as Mean (SD) 
* Reported significant difference from pre; ~ no SD reported 







 Pre Exercise Post Exercise 
 CLAS INTER NC CLAS INTER NC 
Dimitrov, et al, 
2013 
Men and Women 
with Normal and 
Pre-hypertension 
Bruce Protocol 
 ~ 87.9 ~ 4.8 ~ 4.2 ~ 86.7* ~ 5.0 ~ 5.0* 
Van 
Craenenbroeck, 
et al, 2010 
Chronic Kidney 
and Heart Disease 
Patients; Healthy 
Sedentary 
Cycling VO2 Max;  
10-20W/min 
 
HS: 88.1 (4.7) 
CKD: 88.5 (4.3) 
CHF: 87.4 (3.5) 
HS: 4.5 (2.1) 
CKD: 3.6 (1.7) 
CHF: 4.7 (2.5) 
HS: 7.4 (3.2) 
CKD: 8.0 (3.6) 
CHF: 7.9 (2.2) 
HS: 83.1 (6.0) 
CKD: 85.3 (3.7) 
CHF: 85.9 (4.3) 
HS: 5.6 (2.3) 
CKD: 4.4 (1.6) 
CHF: 4.8 (2.2) 
HS: 11.3 (4.6) 
CKD: 10.3 (3.0) 
CHF: 9.4 (3.1) 








 82.2 (5.3) 7.5 (2.4) 10.3 (3.9) 83.9 (4.3) 5.5 (1.9) 10.6 (3.9) 
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Prior to the redefinition, investigations demonstrated selective expansion of CD16+ 
monocytes following exercise, the magnitude of which was dependent on the intensity of 
exercise (Steppich et al., 2000).  Furthermore, the increase in nonclassical monocytes 
following exercise may be related to a mobilization from the marginal pool stimulated by 
the catecholamine response to exercise (Fragala et al., 2011; Kittner et al., 2002).  This 
seems to be consistent even in patients with elevated blood pressure (Hong & Mills, 2008).  
Despite this, the previous studies demonstrated their results without the incorporation of 
the intermediate monocyte population.  With the new nomenclature, the response of the 
intermediate subset must be isolated from the nonclassical population, and defined more 
thoroughly. 
 While the overall count of all monocyte subsets have been demonstrated to increase 
with exercise (Booth et al., 2010; Radom-Aizik et al., 2014; Shantsila et al., 2012), the 
proportion of each subtype in relation to the total population of monocytes may be variable.  
Immediately following aerobic exercise, a significant decrease in the proportion of 
classical monocytes is generally observed (Booth et al., 2010; LaVoy et al., 2015; Radom-
Aizik et al., 2014; Shantsila et al., 2012; Simpson et al., 2009).  This decrease is often 
associated with increases in the proportion of nonclassical only (Booth et al., 2010; 
Dimitrov et al., 2013; Radom-Aizik et al., 2014; Simpson et al., 2009), while others report 
a significant increase in the proportion of both intermediate and nonclassical monocytes 
(LaVoy et al., 2015).  The difference observed between the former and latter investigations 
may be related to differences in the gender of the participant populations.  LaVoy and 
colleagues (2015), utilized a mixed gender group of participants.  The nonclassical 
monocyte population appears to respond differently to exercise in women than men 
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(Heimbeck et al., 2010), which suggests that the use of a mixed gender population may 
result in a different or varied response.  Currently, to the best of our knowledge, there does 
not appear to be any data available regarding the monocyte subset response to resistance 
exercise.   
 Only two studies appear to have examined the response of monocyte subsets one 
hour post-aerobic exercise, and the response was unclear.  Initially, Simpson and 
colleagues (2009) reported a significant increase in the proportion of classical monocytes, 
and a decrease in the proportion of both intermediate and nonclassical subsets one hour 
following endurance exercise.  Subsequently, Booth and colleagues (2010) reported no 
differences in the monocyte subset proportions one hour post-exercise.  These differences 
may have been related to differences in either the exercise modality used or the training 
status of the participants.  Briefly, “moderately trained” participants completed 45 minutes 
of running (Simpson et al., 2009), compared to “athletes” completing a 60km cycling time 
trial (Booth et al., 2010).  Considering that running produces greater muscle damage, 
especially in moderately trained individuals, than cycling (Millet & Lepers, 2004), it stands 
to reason that a greater extent of muscle damage may have contributed to the greater 
response observed with running.   
 Due to the absence of examinations involving skeletal muscle damage in humans, 
and the heterogeneity that exists between the murine and human models of monocyte 
subsets, it is unclear whether the intermediate subset responds to tissue damage.  Evidence 
from the ischemic model of tissue injury indicates a potential link between tissue damage 
and mobilization of the intermediate subset (Tapp et al., 2012; Zhu et al., 2015).  Following 
acute ischemic injury, patients have demonstrated an elevated proportion of intermediate 
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from 1-7 days following an acute myocardial infarction (Tapp et al., 2012), and two days 
following a stroke (Urra et al., 2009).  Although speculative, these data suggest a potential 
relationship between the proportion of intermediate monocytes and tissue damage. 
  
Chemokine Response to Exercise 
 As stated previously, cytokines function as messengers between cells (Nicod, 
1993). Chemokines form a family of cytokines that function primarily as chemoattractants 
for immune cells (Rollins, 1997). While chemokines typically recruit specific immune cells 
to the site of tissue damage, several other cytokines elicit specific responses from immune 
cells (Calle & Fernandez, 2010; Pedersen, Akerstrom, Nielsen, & Fischer, 2007).  As the 
immune cells respond to signals from cytokines and chemokines, a pro- or anti-
inflammatory environment is formed, leading to the classification of cytokines as pro- or 
anti-inflammatory (Calle & Fernandez, 2010).  While several cytokines and chemokines 
are active during recovery from muscle damage, for the purpose of this review, we will 
focus on the chemokines known to recruit specific immune cells, including interleukin-8 
(IL-8), monocyte chemoattractant protein-1 (MCP-1), and fractalkine (CX3CL1). 
 
Interleukin-8 (IL-8) 
 Interleukin 8 (IL-8) is a CXC chemokine (CXCL8) that has been suggested to 
perform two primary functions; neutrophil activation and angiogenesis (Pedersen et al., 
2007; Rollins, 1997).  IL-8 is known to interact with two CXC chemokine receptors 
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(CXCR1 and CXCR2) (Pedersen et al., 2007; Schraufstatter, Chung, & Burger, 2001), and 
is produced by a variety of cells/tissues, including monocytes (Cros et al., 2010; Wong et 
al., 2011), as well as adipose and muscle tissue (Bruun et al., 2004; Chan, Carey, Watt, & 
Febbraio, 2004; Nieman et al., 2003).  Despite the multitude of production locations, it is 
likely that IL-8 produced by adipose tissue contributes little to the activation of neutrophils 
(Ribeiro et al., 1991).  Therefore, the chemotactic properties of IL-8 on neutrophils are 
likely due to production from the myeloid cellular lineage or skeletal muscle. 
 Production of IL-8 within skeletal muscle has been demonstrated following both 
aerobic (Chan et al., 2004; Nieman et al., 2003) and resistance exercise (Chan et al., 2004; 
Nieman et al., 2004).  Although not directly compared (analyses were completed by the 
same research group), the change in mRNA expression of IL-8 from pre to post exercise 
appears to be lower following high volume resistance exercise when compared to high 
volume running (Nieman et al., 2004; Nieman et al., 2003).  Della Gatta and colleagues 
(2014) also demonstrated an increased mRNA expression of IL-8 following resistance 
exercise, which corresponded to an increased concentration of IL-8 within skeletal muscle.  
However, whether this increase in skeletal muscle IL-8 concentration is translatable to IL-
8 in circulation is uncertain. 
Increases in circulating IL-8 have been reported following exercise consisting of 
both concentric and eccentric muscle actions (Pedersen et al., 2007).  Therefore, it is not 
surprising to find significant increases in circulating IL-8 following running exercise 
(Nieman et al., 2003), but not after concentrically based exercises, such as cycling and 
rowing (Chan et al., 2004; Henson et al., 2000).  It stands to reason that with the response 
of neutrophils to tissue damage (Tidball, 2005), and the chemotactic properties of IL-8 on 
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neutrophils (Ribeiro et al., 1991; Rollins, 1997) that skeletal muscle damage may be a 
requisite stimulus for increases in IL-8 concentrations in circulation. 
 Resistance exercise though has not demonstrated the expected results in regard to 
circulating IL-8.  Most investigations that have examined circulating IL-8 following 
resistance exercise, or exercise designed to elicit muscle damage, have reported no change 
(Buford et al., 2009; Paulsen et al., 2005; Ross et al., 2010), while one investigation 
demonstrated a decrease in response to exercise (Hirose et al., 2004).  However, increased 
circulating IL-8, in conjunction with increased mRNA expression of IL-8 in skeletal 
muscle, has been reported following high volume resistance exercise (Nieman et al., 2004).  
A plausible explanation for the different results observed could be related to the total 
volume of exercise completed. 
 To our knowledge, only one study has demonstrated a significant increase in 
circulating IL-8 concentrations following resistance exercise.  This study required 
participants to perform 4 sets of 10 repetitions of 10 different multi-joint, whole body 
exercises.  The first set was performed at 40% of the one-repetition maximum (1RM) and 
60% 1RM for sets 2-4 (Nieman et al., 2004).  In contrast, no changes in IL-8 concentrations 
were noted following one investigation requiring participant to perform 300 forced 
eccentric repetitions of the knee extensor exercise (Paulsen et al., 2005), or 50 eccentric 
contractions of the leg press exercise (Ross et al., 2010).  Furthermore, Buford and 
colleagues (2009) utilized a dynamic resistance exercise bout requiring 3x10 repetitions of 
the squat, leg press and leg extension exercises.  Although no change in circulation IL-8 
concentrations were reported, they did observe a significant increase in the mRNA 
expression of IL-8 (Buford et al., 2009).  Interestingly, Hirose et al (2004) demonstrated a 
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decrease in IL-8 concentrations following forced eccentric exercise of the elbow flexors (4 
x 5 repetitions), which consequently was the lowest volume of all the studies 
examined(Hirose et al., 2004).  Thus, each investigation that reported no change or 
decreased concentrations of IL-8 incorporated significantly less volume of exercise than 
Nieman and colleagues (2004).  Therefore, IL-8 concentrations may only increase in 
circulation following exercise of sufficient volume, however, further investigation appears 
needed. 
 
Monocyte Chemoattractant Protein -1 (MCP-1/CCL2) 
 Monocyte chemoattractant protein-1 (MCP-1) is a member of the CC subfamily of 
chemokines, and is also referred to as CCL2 (Yadav et al., 2010).  Of the many proposed 
functions of MCP-1, monocyte chemoattraction appears to be its primary responsibility, 
principally for classical monocytes (Wong et al., 2012; Yadav et al., 2010; Yang et al., 
2014).  Furthermore, the primary receptor responsible for ligation of MCP-1 is the CC 
chemokine receptor CCR2 (Rot & von Andrian, 2004; Yadav et al., 2010).  Production of 
MCP-1 occurs in the endothelial cells, classical monocytes, and within skeletal muscle 
tissue (Cros et al., 2010; Cushing et al., 1990; Della Gatta et al., 2014; Wong et al., 2011).  
With the pivotal role of classical monocytes during recovery from resistance exercise, the 
investigation of MCP-1 in response to resistance exercise is warranted.  Despite this, the 
examination of MCP-1 in circulation following resistance exercise is rather limited. 
 To our knowledge, only two investigations have examined the effects of dynamic 
resistance exercise on circulating MCP-1 concentrations.  A previous investigation 
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demonstrated elevated mRNA expression of MCP-1 within skeletal muscle following 
resistance exercise, which also translated into an increased expression of MCP-1 within the 
skeletal muscle tissue for up to four hours (Della Gatta et al., 2014).  However, this study 
did not examine circulating changes in MCP-1 concentrations (Della Gatta et al., 2014).  
In another investigation, Ihalainen and colleagues (2014) demonstrated no change in MCP-
1 concentrations following two different exercise bouts (15 x 1-RM or 5 x 10 repetitions 
at 80% 1-RM) immediately, or 15-min post-exercise.  However, a significant decrease in 
MCP-1 concentrations were observed 30 minutes post-exercise.  Conversely, Wells and 
colleagues (2016) reported a significant, immediate increase of circulating MCP-1 in 
response to both a high volume and a high intensity bout of resistance exercise for at least 
5-hours post-exercise.  A reasonable explanation for the discrepancy in these reports is the 
level of muscle damage that was elicited.  Ihalainen et al. (2014) observed 2-fold increase 
in myoglobin concentrations, versus the 5-8 fold increase observed by Wells and 
colleagues (2016).  Thus, the extent or magnitude of skeletal muscle damage may provide 
further insight to the cause of increased MCP-1 concentration. 
 Previous work investigating exercise designed to elicit muscle damage (e.g. 
downhill running, etc.,) has indicated a significant increase in circulating MCP-1 
immediately following exercise (Crystal, Townson, Cook, & LaRoche, 2013; Paulsen et 
al., 2005; J. M. Peake, K. Suzuki, M. Hordern, et al., 2005).  These responses appear to be 
maintained for at least six hours following damage before returning to resting levels by 24 
hours post-exercise (Crystal et al., 2013; Paulsen et al., 2005).  Crystal and colleagues 
(2013) also demonstrated a biphasic response of MCP-1, with initial increases immediately 
following exercise, and a subsequent increase at 6H that may be attenuated with cold water 
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immersion (Crystal et al., 2013).  Peake and colleagues (2005) also demonstrated 
significant increases in MCP-1 concentrations at 1-hr post-exercise.  Greater increases, 
however, were observed following high intensity running (85% of VO2max for 60 min) 
than after downhill running (-10% gradient; 60% VO2max for 45 min) (J. M. Peake, K. 
Suzuki, M. Hordern, et al., 2005).   
It is unclear whether the volume of exercise, or the level of muscle damage 
regulates circulating MCP-1 concentration.  Wells and colleagues (2016) suggested that 
volume of exercise may explain the different results obtained in the investigations utilizing 
dynamic resistance exercise.  Considering that both of these investigations reported no 
differences between high and low volume exercise (Ihalainen et al., 2014; Wells et al., 
2016), we argue that muscle damage may be a more likely explanation.  Nonetheless, 
further research is warranted to determine the impact of muscle damage or the volume of 
exercise on MCP-1 concentrations. 
Fractalkine (CX3CL1) 
 Fractalkine is the sole member of the CX3C chemokine family (CX3CL1), and is 
the primary chemokine responsible for the recruitment and activation of nonclassical 
monocytes (Bazan et al., 1997), and Th cells (Foussat et al., 2000).  Additionally, CX3CL1 
will ligate with the CX3C chemokine receptor CX3CR1 (Ancuta et al., 2003), which is 
prominent on both intermediate and nonclassical monocytes (Cros et al., 2010; Wong et 
al., 2011).  CX3CL1 is produced by endothelial cells under inflammatory conditions, 
namely through interaction with TNF-α and INFγ (Ludwig et al., 2002) as well as within 
skeletal muscle tissue following exercise (Catoire et al., 2014; Della Gatta et al., 2014; 
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Stromberg et al., 2016).  CX3CL1 produced in endothelial cells, however, is bound to the 
endothelial membrane, and serves as an adhesion molecule during transmigration of 
monocytes and lymphocytes to sites of damage (Ancuta et al., 2003; Fong et al., 1998; Imai 
et al., 1997).  Soluble CX3CL1 (sCX3CL1) is released into circulation, when it is cleaved 
from the endothelial cell, and will promote chemotaxis of monocytes and Th cells alike 
(Ancuta et al., 2003; Foussat et al., 2000).  The cleaving of CX3CL1 occurs in the presence 
of pro-inflammatory cues, such as TNF-α and IL-1β (Turner, Mangnall, Bird, Blair-Zajdel, 
& Bunning, 2010).  As a result, elevations of sCX3CL1 can be expected in circulation 
during inflammatory conditions that increase both TNF-α and IL-1β. 
 Prior to 2014, no investigations examined the impact of exercise on CX3CL1 or 
sCX3CL1.  Since then, three investigations have been published demonstrating increased 
skeletal muscle mRNA expression of CX3CL1 (Della Gatta et al., 2014), as well as 
increased CX3CL1 within skeletal muscle (Stromberg et al., 2016) and plasma (Catoire et 
al., 2014).  Catorie and colleagues (2014) observed a significant increase in mRNA 
expression of CX3CL1 following one hour of unilateral cycling (at 50% of their unilateral 
VO2 max).  The increase in mRNA expression translated to a significant increase in 
circulating sCX3CL1 immediately, and 2-hrs post-exercise (Catoire et al., 2014).  
Following resistance exercise, Della Gatta and colleagues (2014) demonstrated significant 
increases in mRNA expression of CX3CL1 at 2-hrs, but not 4-hrs, post exercise.  Recently, 
Stromberg et al. (2016) observed significant increases in CX3CL1 mRNA expression 30 
minutes following bilateral cycling (Workload: 50% of VO2 max for one hour), and a 
subsequent return to baseline at 2-hrs post-exercise.  The mRNA expression of CX3CL1 
paralleled an increase in CX3CL1 protein content observed within skeletal muscle 
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(Stromberg et al., 2016).  However, it is unclear if the CX3CL1 observed within the skeletal 
muscle was bound to endothelial cells or whether it was soluble.   
Evidence is clear that both aerobic and resistance exercise will increase mRNA 
expression of CX3CL1, however, the time course of sCX3CL1 and CX3CL1 mRNA 
expression appears to be quite variable.  It appears that elevations in mRNA expression of 
CX3CL1 is delayed following resistance exercise compared to aerobic exercise (Della 
Gatta et al., 2014; Stromberg et al., 2016).  However, Della Gatta and colleagues (2014) 
did not assess mRNA expression of CX3CL1 prior to 2-hr post-exercise.  Consequently, 
whether the increase in mRNA expression of CX3CL1 observed at 2-hr post-exercise is a 
sustained or a delayed response remains unclear (Della Gatta et al., 2014).  Furthermore, 
the suggestion that increases in mRNA expression within skeletal muscle prompts 
sCX3CL1 increases in circulation (Catoire et al., 2014), has yet to be definitively 
demonstrated following resistance exercise.  Therefore, further investigation is required to 
elucidate the time course of CX3CL1 and sCX3CL1 following resistance exercise. 
 
The αMβ2 Integrin, MAC1/CR3 (CD11b/CD18) 
Macrophage-1 antigen (MAC1) or complement receptor 3 (CR3) is a heterodimeric 
integrin that consists of two subunits, αM (CD11b) and the common β2 subunit (CD18) 
(Ehlers, 2000).  As one of the most studied integrins, the vast array of functions associated 
with MAC1/CR3 range from a potent phagocytic stimulator (Tan, 2012) to providing a 
pivotal role in immune cell migration (Ley et al., 2007).  Furthermore, MAC1/CR3 can be 
activated by several methods, including ligation with P-selectin glycoprotein ligand-1 
46 
 
(PSGL1) (Evangelista et al., 1999), or activation through inflammatory cytokines, like 
TNFα (Montecucco et al., 2008).  Despite the vast, and varied roles of MAC1/CR3, the 
greatest impact on overall immune function appears to be its role in endothelial migration.   
 As immune cells are attracted to the site of damaged tissue through an intricate 
signaling network of chemokines (Freidenreich & Volek, 2012; Rollins, 1997), they 
encounter the endothelial wall, which acts as the final barrier to the damaged tissue 
(Gerhardt & Ley, 2015).  Immune cells will systematically employ specific adhesion 
molecules that mediate the transendothelial migration to the tissue, a process referred to as 
the leukocyte adhesion cascade (Ley et al., 2007).  Furthermore, molecules within the 
leucocyte adhesion cascade can be divided into two primary sub-categories, selectins and 
integrins, while the cascade itself can be divided into five major processes: tethering, 
rolling, adhesion, crawling and extravasation (Gerhardt & Ley, 2015). 
During the leukocyte adhesion cascade, selectins primarily function during the 
early phases (tethering and rolling), while the integrins function primarily in the later 
phases (adhesion, crawling and extravasation) (Kolaczkowska & Kubes, 2013).  Briefly, 
the adhesion cascade is initiated by the ligation of PSGL-1 to its receptors on the 
endothelial wall, P-selectin, and later E-selectin (Evangelista et al., 1999; Kansas, 1996).  
Following the initial tethering, P- and E-selectin as well as PSGL-1 on the leukocyte 
continue the rolling process, gradually progressing to a slow rolling state with increasing 
contribution from L-selectin (CD62L) (Ley et al., 2007).  As the rolling phase continues to 
slow, integrins become more involved, until adhesion can occur.  Adhesion is mediated by 
the cell adhesion molecules intracellular adhesion molecule-1 (ICAM1) and vascular cell 
adhesion molecule-1 (VCAM1) located on the endothelial surface, and the integrin 
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lymphocyte function-associated antigen-1 (LFA-1) located on the immune cell (Tan, 
2012).  Crawling, which is mediated by the interaction of ICAM1 with MAC1/CR3, is 
initiated once the cells are firmly adhered to the vessel wall.  It requires slight movement 
to position the leukocyte over the endothelial junction to allow for transmigration into the 
damaged tissue through a paracellular route (Ley et al., 2007).  While transcellular 
migration across the endothelium is possible, evidence suggests immune cells 
preferentially migrate by paracellular means (Gerhardt & Ley, 2015).  Furthermore, 
MAC1/CR3 aides in the paracellular migration of immune cells by interacting with 
junctional adhesion molecules near the endothelial junctions (Gerhardt & Ley, 2015).  
While each process is required for complete migration to the location of damage, the 
specific modulation of MAC1/CR3 has also been demonstrated to modify immune cell 
infiltration. 
Increased expression of MAC1/CR3 on monocytes has been implicated in 
increased adherence to the endothelial wall (Weber, Erl, & Weber, 1995).  Likewise, 
decreased expression of MAC1/CR3 leads to decreased adhesion to the endothelial wall 
(Arakawa et al., 2010).  Similarly, mice that are injected with anti-CD11b toxin display 
limited infiltration into damaged tissue (Rosen & Gordon, 1987).  Direct activation of 
MAC1/CR3 on neutrophils is mediated through the pro-inflammatory cytokine TNF-α 
(Montecucco et al., 2008).  Recent evidence suggests a relationship between MAC1/CR3 
expression on monocytes and MCP-1 (Wells et al., 2016).  Evidence appears to indicate a 





MAC1/CR3 Responses to Exercise Stress 
An efficient transmigration of cells into the damaged tissue is paramount to optimal 
recovery, underlining the importance of MAC1/CR3 in the recovery process.  While 
MAC1/CR3 has been examined frequently, there is still little consensus on the overall 
response and time course of MAC1/CR3 expression on leukocytes following exercise.  
This is likely due to the vast array of exercise protocols that have been examined (Gavrieli 
et al., 2008; Jordan et al., 1999).   
 
Neutrophil Expression of MAC1/CR3 following Exercise 
Aerobic exercise has often been used to examine the expression of CD11b in 
response to exercise.  No change in CD11b expression on neutrophils were reported by two 
investigations in response to moderate duration and intensity exercise (30 min at 75% VO2 
max or 60 min at 60% VO2 max) (Gavrieli et al., 2008; Kurokawa, Shinkai, Torii, Hino, & 
Shek, 1995).  Similarly, Jordan and colleagues (1999) demonstrated no significant change 
in CD11b expression following moderate intensity (50-60%) running for three hours.  
However, during prolonged endurance events (i.e. a marathon) CD11b expression was 
demonstrated to both increase (Jordan et al., 1999) and remain at pre-exercise levels 
(Nielsen & Lyberg, 2004).  While these results are conflicting, differences in 
environmental stresses and hydration status may have influenced these results (Jordan et 
al., 1999). 
As exercise intensity increases, there appears to be greater consistency of the 
MAC1/CR3 response on neutrophils.  Graded exercise tests have been a common mode of 
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exercise to examine the neutrophil expression of MAC1/CR3 at maximal effort.  Studies 
using this exercise model consistently demonstrate significant increase in CD11b 
expression immediately following exercise (Jordan et al., 1999; van Eeden et al., 1999).  
Increases in the expression of CD11b following graded exercise was reported within 
minutes of the initial exercise stimulus, and remained elevated for at least 30 minutes post-
exercise (van Eeden et al., 1999).  Furthermore, Gabriel and Kindermann (1998) 
demonstrated an increase in the expression of CD11b immediately following an intense 
(110% of anaerobic threshold for approximately 20 minutes) bout of cycling exercise, with 
a subsequent decrease in expression two hours into recovery.  
 Exercise designed to elicit muscle damage has also been used to examine 
MAC1/CR3 expression on granulocytes, producing equivocal results (J. M. Peake, K. 
Suzuki, G. Wilson, et al., 2005; Pizza et al., 1996; Saxton et al., 2003).  Pizza and 
colleagues (1996) initially examined the effects of forced eccentric elbow flexion on 
granulocyte CD11b expression.  Interestingly, increases were observed only between 24 
and 96 hours following exercise (Pizza et al., 1996), long past the expected time course of 
neutrophil activation (Kolaczkowska & Kubes, 2013).  Others observed no changes in 
neutrophil expression of CD11b following exercise induced muscle damage (J. M. Peake, 
K. Suzuki, G. Wilson, et al., 2005; Saxton et al., 2003), but they used direct isolation 
methods to identify granulocytes.   
 Expression of MAC1/CR3 on granulocytes appears to be modulated primarily by 
exercise intensity, particularly as a function of VO2 max (Gabriel & Kindermann, 1998; 
van Eeden et al., 1999).  Of the investigations presented, significant increases were most 
consistently observed when near maximal effort was used (Gabriel & Kindermann, 1998; 
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van Eeden et al., 1999).  Consequently, it seems that exercise induced muscle damage may 
not affect neutrophil expression of MAC1/CR3.  However, to our knowledge, no 
investigations have examined neutrophil expression of MAC1/CR3 in response to a 
dynamic resistance exercise bout, demonstrating the need for further investigation in the 
area of resistance exercise.   
 
Monocyte Expression of MAC1/CR3 following Exercise 
 Similar to the MAC1/CR3 expression on neutrophils, the characterization of the 
MAC1/CR3 response to exercise on monocytes has been ambiguous.  Increases in CD11b 
expression have been previously demonstrated following both a marathon and half-
marathon (Nielsen & Lyberg, 2004).  Furthermore, the use of dynamic body weight 
exercises (5 sets of 30 lunge exercises) have also demonstrated significant elevations in 
CD11b expression on monocytes during recovery (Malm et al., 1999).  However, studies 
using exercise modalities that induce acute muscle damage have yielded inconsistent 
results.  In a study on recreationally active men no change in CD11b expression on 
monocytes was reported following 50 eccentric contractions of the knee extensors (Saxton 
et al., 2003).  In contrast, Pizza and colleagues (1996) demonstrated significant elevations 
in CD11b expression 24 hours following 25 eccentric contractions of the elbow flexors in 
untrained individuals.  It is likely that training experience of the participants contributed to 
these differences.  Still, the exercise stimuli employed by both studies were isolated 
movements, and may not be translatable to dynamic resistance exercise.   
 Following dynamic resistance exercise the expression of CD11b on monocytes has 
been  reported to increase 30-min following exercise, and return to resting levels at 24- and 
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48-hrs post exercise (Gonzalez et al., 2014; Jajtner et al., 2014).  Recently, Wells and 
colleagues (2016) demonstrated a significant increase in CD11b expression on monocytes 
immediately, and 1-hr post-exercise.  The immediate increase contrasts with the findings 
of Jajtner et al. (2014) and Gonzalez, et al. (2014), who demonstrated no significant 
increase immediately following exercise.  While each study utilized experienced, 
resistance-trained participants performing an acute bout of resistance exercise, the 
differences could be attributable to the identification of monocytes in each study.  Gonzalez 
et al. (2014) and Jajtner et al. (2014) identified monocytes with CD14 exclusively 
(CD14++).  In contrast, Wells and colleagues (2016) utilized CD14 in conjunction with 
CD16 to identify classical monocytes (CD14++/CD16-).  As intermediate and classical 
monocytes express CD14 at similar levels (Wong et al., 2012), it is likely the CD14++ 
monocytes analyzed by Gonzalez et al (2014) and Jajtner et al (2014) incorporated both 
classical and intermediate monocytes.  Furthermore, classical and intermediate monocytes 
are both known to express CD11b (Wong et al., 2012).  While speculative, the inclusion of 
intermediate monocytes may have influenced the expression of CD11b on the CD14++ 
monocytes reported by Gonzalez et al. (2014) and Jajtner et al. (2014).  However, to our 
knowledge, no investigation has examined the CD11b response on intermediate 
monocytes.  Therefore, future research examining the impact of dynamic resistance 





 Polyphenols are micronutrients that are the most plentiful antioxidant in the diet, 
and are common in many plant-based foods and beverages, such as fruits, tea and coffee 
(Manach, Scalbert, Morand, Remesy, & Jimenez, 2004; Scalbert, Johnson, & Saltmarsh, 
2005).  Polyphenols are characterized by their structure, which contains multiple hydroxyl 
groups on aromatic rings (Manach et al., 2004).  Based on their structure, polyphenols are 
broken into four main classifications, phenolic acids, flavonoids, stilbenes, and lignans 
(Manach et al., 2004).  Flavonoids can be further classified into six distinct classifications, 
and appear to be the most common polyphenol supplement examined with exercise 
(Manach et al., 2004; Myburgh, 2014).   
Human cells continually produced reactive oxygen species (ROS), a process that is 
intensified during exercise (Merry & Ristow, 2015; Urso & Clarkson, 2003).  As 
polyphenols are known antioxidants, their use during and following exercise has been the 
subject of recent investigation (Bowtell et al., 2011; Jowko et al., 2011; Panza et al., 2008).  
Acute polyphenol supplementation has been demonstrated to reduce strength deficits 
following exercise that elicits muscle damage (Herrlinger et al., 2015; Machin et al., 2014), 
as well as resistance exercise (Bowtell et al., 2011; Jowko et al., 2011; Panza et al., 2008).  
Data regarding polyphenol supplementation and the immune response to exercise, 
however, is limited. 
Most investigations that have examined polyphenol supplementation and the 
exercise response have employed a high volume aerobic exercise model.  Nieman and 
colleagues (2013) assessed changes in cytokine concentration following three days of high 
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volume running (2.5-hr at 65% VO2max) with or without polyphenol supplementation.  
While all measured cytokines (IL-6, IL-8, IL-10, MCP-1, G-CSF and TNF-α) increased 
due to exercise, no differences were observed in response to polyphenol supplementation 
(Nieman et al., 2013).  Similarly, no differences in plasma cytokine concentration (IL-1ra, 
IL-6, IL-8, IL-10, MCP-1, G-CSF or TNF-α) were reported following a 163km running 
race between placebo or quercetin supplementation (Nieman, Henson, Davis, et al., 2007).  
Cycling at ~57% on of VO2max for 3-hr on three consecutive days also demonstrated no 
differences in immune cell populations between quercetin and placebo groups (Nieman, 
Henson, Gross, et al., 2007).  Additionally, polyphenol supplementation resulted in no 
differences following downhill running or repeated sprints on a cycle ergometer for TNF-
α, IL-1β and IL-6, or IL-6 alone, respectively (Arent, Senso, Golem, & McKeever, 2010; 
Herrlinger et al., 2015).  Similarly, Kerksick and colleagues (2010) showed no differences 
in TNF-α concentration following 100 eccentric contractions of the leg extensors in 
conjunction with EGCG supplementation.  However, a significant decrease in the number 
of neutrophils were observed 24-72 hours following exercise with ECGC supplementation 
for 14 days (Kerksick et al., 2010).  Although polyphenol supplementation does not 
influence the cytokine response to exercise, evidence does suggest that EGCG 
supplementation can suppress the neutrophil response to eccentric exercise eliciting muscle 
damage.  Nevertheless, no changes in the granulocyte population have been reported 
following quercetin supplementation and high volume exercise.   
Polyphenols, appear to elicit their effects within the context of immune cell 
adhesion.  Evidence from in vitro modeling have demonstrated significant downregulation 
of CD11b on the surface of both monocytes and neutrophils, as well as limited chemotaxis 
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(Graff & Jutila, 2007; Kawai et al., 2004; Takano et al., 2004).  Evidence of reduced CD11b 
expression on monocytes in response to polyphenol supplementation has also been 
presented in clinical populations (Chiva-Blanch et al., 2012).  However, there does not 
appear to be any investigations conducted examining the response of CD11b expression to 
exercise in conjunction with polyphenol supplementation. 
 
Conclusions 
 Previous investigations of the immune response to exercise and exercise induced 
muscle damage have elucidated many distinct functions of myeloid and non-myeloid cells 
during recovery.  Following tissue injury, patrolling nonclassical monocytes and resident 
macrophages initiate the release of specific cytokines and chemokines.  These in turn 
activate endothelial cells, and stimulate the recruitment of myeloid cells.  First to arrive at 
the site of tissue damage are the neutrophils, followed by classical monocytes.  Classical 
activation of these monocytes leads to the development of M1 macrophages, and 
subsequently, M2 macrophages.  During the earliest phases of recovery, neutrophils and 
M1 macrophages promote an inflammatory environment, while M2 macrophages promote 
an anti-inflammatory milieu during the late phase of recovery.  Despite an inflammatory 
environment, the early phase of recovery plays a pivotal role in the remodeling of skeletal 
muscle.  MPC are known to proliferate during the M1 phase, while the M2 phase of 




 Within circulation, the myeloid cells also actively contribute to the recovery 
process.  The heterogeneity of monocytes within circulation has gained interest in recent 
years with the formal definition of an intermediate monocyte population.  Furthermore, 
each monocyte subset has specific responsibilities within the context of skeletal muscle 
recovery.  Classical monocytes infiltrate damaged tissue and give rise to M1 macrophages, 
while also displaying a strong phagocytic capacity.  Intermediate monocytes are 
inflammatory cells that assist with antigen presentation to T-cells, while nonclassical 
monocytes patrol the endothelial wall.  As each subset has distinct responsibilities, the 
propensity of each subset to adhere and transmigrate into damaged tissue is of interest.  
While both classical and intermediate monocytes express the cell adhesion molecule 
MAC1/CR3, examination of this marker provides an indication of the tendency of these 
cells to migrate to damaged tissue.   
 Though many processes of the immune response have been elucidated, many 
questions remain.  The focus of our knowledge on the monocyte subset response to exercise 
has been primarily achieved using aerobic exercise but our understanding of monocyte 
subset redistribution in response to resistance exercise is lacking.  Furthermore, increases 
in MAC1/CR3 expression likely lead to extravasation of myeloid cells, however, the 
response of different monocyte subsets, namely the inflammatory intermediate monocytes, 
to resistance exercise is unknown.  Additionally, polyphenol supplementation is known to 
suppress the expression of MAC1/CR3 on monocytes and neutrophils.  However, the 
application of polyphenol supplementation to recruitment of myeloid cells following 
exercise has yet to be examined.  Given the necessity of macrophage infiltration for 
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complete recovery of skeletal muscle, exercise and supplementation programs that 
maximize myeloid extravasation may be indicative of enhanced recovery.  
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CHAPTER 3: DESIGN AND METHODOLOGY 
 
Participants 
Thirty-six recreationally active males between the ages of 18 and 35 volunteered to 
participate in this study.  Participants were randomly assigned to one of three groups.  The 
first group (PPB; N=13, 21.8 ± 2.5 y, 171.2 ± 5.5 cm, 71.2 ± 8.2 kg, 24.3 ± 2.8 kg/m2) 
consumed 2 g per day of the proprietary polyphenol blend supplement; the second group 
(PL; N = 15, 21.6 ± 2.5 y, 176.5 ± 4.9 cm, 84.0 ± 15.7 kg, 26.9 ± 4.2 kg/m2) consumed 2 g 
per day of the placebo and the third group (CON; N = 9, 23.6 ± 4.5 y, 174.0 ± 13.4 cm, 
78.3 ± 16.9 kg, 25.7 ± 3.5 kg/m2) served as control.  Following an explanation of all 
procedures, risks and benefits, each participant provided his informed written consent prior 
to completing any testing.  For inclusion in the study, participants had to complete less than 
three hours of planned exercise per week, have a body mass index of 18.0-34.9 kg/m2, be 
free of physical limitations, and be willing to maintain a habitual diet while abstaining from 
dietary supplements.   
 
Study Design 
All groups reported to the human performance lab for five days of testing (Figure 
5).  Prior to the first day of testing, PPB and PL completed a 28-day supplementation 
protocol.  Day 1 consisted of 1-repetition maximum (1-RM) testing of the squat, leg press 
and leg extension exercises, and occurred at least 72 hours prior to the second day of the 
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study.  On day 2, participants arrived in the lab 12 hours postprandial, and provided a 
resting blood sample (PRE).  After blood samples were obtained, participants were 
provided a small breakfast bar (Cal: 190, CHO: 19g, Protein: 7g, Fat: 13g) and then 
completed performance testing.  After performance testing was complete, CON rested for 
one hour, while PPB and PL began the acute exercise protocol.  Participants provided blood 
samples immediately post- (IP), 1-hour (1H) and 5-hours (5H) post-exercise, and 
completed performance testing at 1H following the damaging protocol.  Immediately 
following the performance measures at 1H, participants were provided with a light meal 
(Cal: 250, CHO: 34g, Protein: 14g, Fat: 6g).  Participants returned to the lab in a fasted 







Figure 5: Study Design.  
Participants completed 1-RM testing at least 72 hours prior the exercise protocol.  
During day 2, participants completed a muscle damaging workout, and provided 
blood samples pre exercise (PRE), immediately (IP), 1 hour (1H) and 5 hours 
(5H) post exercise.  Performance testing was completed at PRE and 1H.  
Participants provided additional blood samples and completed performance 
testing 24- (24H), 48-(48H) and 96- (96H) hours following damage.  Flow 




 Both the PPB and PL groups completed daily supplementation for 28 days with 
either a proprietary polyphenol blend (PPB) or placebo (PL) (Kemin Foods, L.C., Des 
Moines, IA, USA).  The PPB group consumed a blend of water-extracted green and black 
tea (Camellia Sinensis) containing at minimum 40% total polyphenols, 1.3% theaflavins, 
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5-8% epigallocatechin-3gallate (EGCG), 7-13% caffeine, 600 ppm manganese.  The PL 
group consumed microcrystalline cellulose in capsules of similar shape and size.  All 
products were tested for toxins including heavy metals, pesticides and excipients by an 
independent third party.   
 Briefly, participants reported to the Human Performance Lab three to five days per 
week to receive the supplement.  Participants took one dose (1000 mg PPB or PL) under 
the supervision of a member of the research team, and were given their prescribed doses in 
individual containers (1000 mg PPB or PL) for each additional time point.  Participants 
consumed two doses per day for a total of 2000 mg of either PPB or PL daily.  Participants 
were asked to return all empty containers upon their next visit to the lab.  Participants that 
did not maintain 80% compliance in each phase (28 days of supplementation or during the 
AP) were removed from analysis. 
 
1-Repetition Maximum Testing 
Direct measurement of one repetition maximal strength (1-RM) was completed on 
the squat and leg press exercises, while a predicted 1-RM was performed on the leg 
extension exercise.  All participants completed a standardized warm-up, consisting of 5 
minutes on a cycle ergometer against a self-selected resistance, 10 body weight squats, 10 
walking lunges, 10 dynamic hamstring stretches and 10 dynamic quadriceps stretches.  All 
1-RM testing was completed as previously described (Hoffman, 2006).  Briefly, each 
participant completed two warm-up sets consisting of 5-10 repetitions and 3-5 repetitions 
at approximately 40-60% and 60-80% of his perceived maximum, respectively.  Each 
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participant then performed up to five subsequent trials to determine his 1-RM with 3-5 
minutes of rest between each set. 
During the squat exercise, participants placed a safety squat bar (Power Lift, 
Jefferson, IA, USA) across their shoulders and descended to the parallel position, where 
the greater trochanter of the femur reached the same level as the knee.  Participants then 
ascended to a complete knee extension.  Leg press was completed with the participant 
sitting in a reclined position, with their legs extended.  Participants were asked to lower the 
weight until the lower leg and femur created a 90° angle.  Participants were then asked to 
press the weight up.  Participants that were unable to complete the repetition or maintain 
proper range of motion were given one additional opportunity.  If they were still unable to 
perform the exercise correctly, the last completed weight was recorded as the 1-RM. 
For the leg extension exercise, participants were placed in a seated position, and 
asked to extend their legs straight out in front of them.  Participants were asked to perform 
as many repetitions as possible, and the resulting repetitions and weight used were applied 
to a prediction equation (Brzycki, 1993).  If more than 10 repetitions were performed, the 
weight was increased and the participant repeated the measure 3-5 minutes later.  All 
testing was observed by a certified strength and conditioning specialist to monitor 
adherence to form.   
 
Acute Exercise Protocol 
 Only PPB and PL completed the protocol, while CON rested for an hour.  The 
exercise protocol designed to cause muscle damage in previously untrained individuals was 
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preceded by a light warm-up as described above.  Following the light warm-up, participants 
completed a resistance exercise session that consisted of six sets of 10 repetitions of the 
squat, as well as four sets of 10 repetitions of the leg press and leg extension exercises.  All 
exercises were completed at 70% of the subjects previously determined 1-RM with 90 sec 
of rest between each set.  Participants were provided with assistance if they were unable to 
complete 10 repetitions on their own, and weight for the subsequent set was reduced.  All 
testing sessions were observed by a certified strength and conditioning specialist to monitor 
adherence to exercise form. 
 
Blood Measurements 
Blood samples were obtained at seven time points throughout the study (PRE, IP, 
1H, 5H, 24H, 48H and 96H).  The PRE, IP and 1H blood samples were obtained using a 
Teflon cannula placed in a superficial forearm vein using a three-way stopcock with a male 
luer lock adapter and plastic syringe.  The cannula was maintained patent using an isotonic 
saline solution (Becton Dickinson, Franklin Lakes, NJ, USA).  PRE and 1H blood samples 
were obtained following a 15-minute equilibration period, while IP blood samples were 
taken within 5-min of exercise cessation.  The remaining time points (5H, 24H, 48H and 
96H) were obtained by a single use disposable needle with the subject in a supine position 
for at least 15 minutes prior to sampling.  Whole blood (20 ml) was collected in two 
Vacutainer® tubes (Becton Dickinson, Franklin Lakes, NJ), one containing K2EDTA, and 
one containing no anti-clotting agents.  Aliquots were removed from the first tube for 
hematocrit and hemoglobin measures, as well as flow cytometry analysis, while the second 
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tube was allowed to clot for 30 minutes prior to being centrifuged at 3,000xg for 15 minutes 
with the remaining whole blood from the first tube.  The resulting plasma and serum was 
aliquoted and stored at -80°C for later analysis.   
 
Circulating Markers 
Hematocrit was analyzed in duplicate from whole blood via microcentrifugation 
(Statspin®, Critspin, Westwood, MA, USA) and microcapillary technique.  Hemoglobin 
was analyzed in duplicate from whole blood using an automatic analyzer (Hemocue®, 
Cypress, CA, USA).  Coefficient of variation for each assay was 0.20% for hematocrit and 
0.46% for hemoglobin.  Plasma volume shifts following the workout were calculated via 
the formula established by Dill and Costill (Dill & Costill, 1974), however, circulating 
values were not adjusted to account for changes in plasma volume. 
Serum concentrations of myoglobin (MG) were obtained via enzyme-linked 
immunosorbent assay (ELISA) (Calbiotech, Spring Valley, CA, USA), while CK was 
analyzed using a commercially available kinetic assay (Sekisui Diagnostics, 
Charlottetown, PE, Canada), per manufacturer’s instructions.  To limit inter-assay 
variability, all samples for a particular assay were thawed once, and analyzed by the same 
technician using a BioTek Eon spectrophotometer (BioTek, Winooski, VT, USA).  All 
samples were analyzed in duplicate with a mean coefficient of variation of 7.57% for MG 
and 3.66% for CK.   
Plasma concentrations of interleukin-1β (IL-1β), IL-6, IL-8, IL-10, monocyte-
chemoattractant protein-1 (MCP-1), fractalkine (CX3CL1), interferon-γ (INF-γ) 
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granulocyte colony stimulating factor (G-CSF) and granulocyte/macrophage colony 
stimulating factor (GM-CSF) were analyzed via multiplex assay, using the human 
cytokine/chemokine panel one (EMD Millipore, Billerica, MA, USA).  All samples were 
thawed once and analyzed in duplicate by the same technician using the MagPix (EMD 
Millipore), with average coefficient of variation of 6.17%, 7.74%, 8.04%, 5.33%, 6.84%, 
7.18%, 8.21%, 7.82%, and 7.10% for IL-1β, IL-6, IL-8, IL-10, MCP-1, CX3CL1, INF-γ, 




Fresh, anti-coagulated (K2EDTA), whole blood (100 µl) was mixed with 
fluorescent-conjugated monoclonal antibodies specific to CD11b-fluorescein 
isothiocyanate (FITC; Biolegend, San Diego, CA, USA), CD66b-phycoerythrin (PE), 
CD14-PerCP Cy5.5 and CD16-allophycocyanin (APC; BD Biosciences, San Jose, CA, 
USA).  Samples were mixed and incubated for 15 minutes in the dark, after which, the 
samples were lysed with 2 ml of 1 x FACS lysing solution (BD Biosciences), mixed and 
incubated in the dark for an additional 8 minutes.  Following incubation, samples were 
centrifuged at 300 x g for 8 minutes and washed with 2 ml of 1 x wash buffer containing 
1% fetal bovine serum (FBS) in a 1 x phosphate buffered saline (PBS) solution.  Samples 
were centrifuged again at 300 x g for 8 minutes, and the supernatant was removed.  Samples 




Data Acquisition and Analysis 
Cell preparations were acquired using an Accuri C6 flow cytometer (BD Accuri 
Cytometers, Ann Arbor, MI, USA) equipped with two lasers providing excitation at 488 
and 640 nm, and 4 band pass filters (FL1: 533/30; FL2: 585/40; FL3 670LP; FL4: 675/25).  
Events were recorded based on size (FSC-A), complexity (SSC-A) and mean fluorescence 
intensity (MFI).  A total of 200 µl were collected for each sample, which ensured at least 
8,000 CD14+ events.   
 Analysis was completed using BD Accuri analysis software (BD Accuri 
Cytometers).  Events were initially gated based on SSC-H and SSC-A as a multiplet cell 
exclusion criteria (Figure 6 A).  Granulocytes were then determined by CD66b positive 
staining (Figure 6 B, C), while monocytes were discriminated into classical, intermediate 
and non-classical monocytes initially by FSC/SSC characteristics (Figure 6 D) and 
secondarily by CD14 and CD16 staining characteristics (Figure 6 E) (Wong et al., 2012), 
with CD66b exclusion (Figure 6 B, C) (Ziegler-Heitbrock et al., 2010). Mean fluorescence 
intensity (MFI) for each of these sub-populations was then determined for CD11b (Figure 
6 F).  Granulocytes are expressed as a percent of leukocytes, and monocyte subsets are 




Figure 6: Gating Procedure.   
All samples were initially gated for multiplet exclusion (A).  Granulocytes were 
identified by staining for CD66b in an unstained control sample (B), and 
compared to samples positively stained for CD66b (C).  Monocytes were initially 
gated in FSC vs SSC characteristic plot with a monocyte gate (D), which were 
assessed for CD66b expression (B/C).  CD66b- monocytes were applied to a 
CD14 vs CD16 two dimensional histogram to identify classical, intermediate and 




Performance testing was performed at PRE, 1H, 24H, 48H and 96H, and consisted 
of maximal voluntary isometric contractions, during which peak torque (PKT) and the rate 
of torque development (RTD) was determined.  During each assessment participants were 
positioned in a BioDex S4 isokinetic dynamometer in a seated position with their hips at a 
110° angle.  Participants were then secured to the device with straps around the waist and 
shoulders, after which, the technicians positioned the knee at a 110° angle (with 180° 
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representing full extension).  The participants were then prompted to kick as forcefully and 
as fast as possible, while maintaining their effort for five seconds.  Each participant was 
provided two attempts, and the highest PKT and RTD was recorded. 
 
Statistics 
Changes in circulating cytokines, markers of muscle damage, immune cell 
characteristics and performance measures were analyzed via repeated measures analysis of 
variance (ANOVA).  In the event of a significant F ratio, LSD post-hoc tests were used for 
pairwise comparisons.  Due to non-normality, circulating cytokines and markers of muscle 
damage were transformed using the natural log (LN).  Area under the curve (AUC) was 
also calculated for changes in the cytokines and myoglobin response using a standard 
trapezoidal technique.  AUC was analyzed via one-way ANOVA.  Raw concentrations 
from PRE, IP, 1H and 5H were used to calculate AUC prior to LN transformation.  
Additionally, Pearson product moment correlations were calculated to examine selected 
bivariate relationships between immune cells, and markers of muscle damage measures.  
Significance was accepted at an alpha level of p≤0.05 and all data are reported as mean ± 





CHAPTER 4: RESULTS 
 
Participant Characteristics 
 Participants were required to maintain 80% compliance during the supplementation 
period to be included in the final analysis.  As a result, 10 participants were removed from 
the investigation prior to analysis (PPB = 6; PL = 4).  Of the 10 participants removed, five 
participants requested to discontinue testing (PPB = 4; PL = 1).  Of the five participants 
that wished to discontinue, one completed a portion of the resistance exercise protocol prior 
to discontinuing the study (PPB group), two reported unresolvable scheduling conflicts 
(both from PPB group), and two discontinued supplementation (PPB = 1, PL = 1).  Five 
additional participants that completed testing were removed from analysis due to lack of 
compliance (PPB = 2; PL = 3).  Four of the five participants were removed for failure to 
achieve 80% compliance with supplementation (PPB = 2; PL = 2) while one did not adhere 
to the fasting requirements (PL group).  A graphical schematic of this is displayed in Figure 
7.  Characteristics of the remaining 39 participants are listed in Table 3.  No significant 




Figure 7: Participant recruitment and randomization.  
Participant screening through the duration of the study.  Compliance was set a 










Table 3: Participant Characteristics.  
Participant characteristics are listed as mean (SD) 
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(6.5) N/A 0.853 
 
Markers of Muscle Damage 
 A significant group x time interaction (F = 19.16, p < 0.001, η2 = 0.523) was 
observed in changes in myoglobin concentrations (see Figure 8).  Post Hoc analysis 
indicated a significant elevation at IP in both PPB (p = 0.004) and PL (p = 0.002) compared 
to CON.  Elevations were maintained at 1H and 5H for both groups (p’s < 0.001) compared 
to CON.  No significant differences in the myoglobin AUC response were observed 




Figure 8: Myoglobin Response to Resistance Exercise. 
Supplement (PPB), placebo (PL) and control (CON) groups were analyzed for 
changes in (A) Myoglobin concentration were analyzed PRE, immediately- (IP), 
one- (1H) and five- (5H) hours post Changes in exercise. (B) Creatine Kinase pre-
exercise (PRE) and 24 (24H), 48 (48H) and 96 (96H) hours after exercise.  
* Significantly different than corresponding value for PRE (p < 0.05) 
^ Significantly different than corresponding value for CON (p < 0.05) 
  
Changes in circulating CK concentrations are depicted in Figure 9.  A significant 
group x time interaction was observed (F = 4.27, p = 0.005, η2 = 0.201) for CK 
concentrations.  Significant elevations from PRE were noted in both PPB and PL at 24, 48 
and 96 hours).  However, CK concentrations at 24H, 48H and 96H were significantly 
greater in PPB compared to PL (p = 0.041, 0.025 and 0.025, respectively) and CON (p ≤ 












































Figure 9: Creatine Kinease Response to Resistance Exercise. 
Supplement (PPB), placebo (PL) and control (CON) groups were analyzed for 
changes in (A) Myoglobin concentration were analyzed PRE, immediately- (IP), 
one- (1H) and five- (5H) hours post Changes in exercise. (B) Creatine Kinase pre-
exercise (PRE) and 24 (24H), 48 (48H) and 96 (96H) hours after exercise.  
* Significantly different than corresponding value for PRE (p < 0.05) 
^ Significantly different than corresponding value for CON (p < 0.05) 
# Significantly different than corresponding value for PL (p < 0.05) 
 
Changes in Maximal Voluntary Isometric Contractions 
 Changes in peak torque in response to resistance exercise are depicted in Figure 10.  
A significant group x time interaction was observed for percent change in peak torque (F 
= 4.52, p = 0.001, η2 = 0.201).   Significant reductions from PRE were noted for PPB and 
PL for every measure (1H – 96H) and for CON from 24H – 48H.  The percent reduction 
from PRE in peak torque at 1H was significantly greater in PBB (p = 0.001) and PL (p = 



































Figure 10: Maximal Voluntary Isometric Torque following Resistance Exercise. 
Supplement (PPB), placebo (PL) and control (CON) groups were analyzed for 
changes in maximal voluntary isometric (A) peak torque and (B) rate of torque 
development.  Changes are assessed as percent difference from pre exercise to 
one- (1H), 24- (24H), 48- (48H), and 96- (96H) hours post exercise. 
* Significantly different than corresponding value for PRE (p < 0.05) 
^ Significantly different than corresponding value for CON (p < 0.05) 
 
Circulating Cytokines 
 Changes in circulating MCP-1 in response to resistance exercise are depicted in 
Figure 11.  A significant group x time interaction was observed between groups (F = 3.17, 
p = 0.003, η2 = 0.150).  Significant differences were noted at 5H between CON and both 
PPB (p < 0.001) and PL (p = 0.006).  Additionally, a trend (p = 0.081) for a difference was 
also noted between CON and PPB at 1H.  Furthermore, a significant interaction between 





































MCP-1 response was significantly greater (p = 0.006) in PPB than CON, and trended 
toward a difference (p = 0.093) when compared to PL.  
 
 
Figure 11: Monocyte Chemoattractant protein-1 (MCP-1) Response to Resistance 
Exercise. 
Supplement (PPB), placebo (PL) and control (CON) groups were analyzed for 
changes in MCP-1 pre exercise (PRE), as well as immediately (IP), one- (1H), 
five- (5H), 24- (24H), 48- (48H) and 96- (96H) hours post exercise. 
* Significantly different than corresponding value for PRE (p < 0.05) 
^ Significantly different than corresponding value for CON (p < 0.05) 
































Figure 12: Monocyte Chemoattractant protein-1 (MCP-1) Area under the Curve 
Response to Resistance Exercise. 
Supplement (PPB), placebo (PL) and control (CON) groups were analyzed for 
Area under the curve comparison between PPB, PL and CON. 
* Significantly different than CON (p < 0.05) 
 
 No significant group x time interaction was observed for CX3CL1 (F = 1.081, p = 
0.380, η2 = 0.060), however a significant time effect was observed (F = 16.118, p < 0.001, 
η2 = 0.322).  When collapsed across groups, pairwise comparisons indicated significant 
elevations from PRE (149.1 ± 84.9 pg/ml) at IP (184.7 ± 70.9 pg/ml; p < 0.001) and 1H 
(171.9 ± 73.8 pg/ml; p = 0.002), and suppression at 48H (130.5 ± 66.4 pg/ml; p = 0.025).  
In addition, elevations at IP was significantly higher than 5H (165.2 ± 107.8 pg/ml; p = 
0.007), 24H (138.9 ± 74.3 pg/ml; p < 0.001), 48H (p < 0.001) and 96H (p < 0.001), while 





























(p < 0.001, p < 0.001, respectively) and 96H (p < 0.001, p = 0.011, respectively).  
Furthermore, no significant interaction was observed for the CX3CL1 AUC response 
between groups (F = 0.0859, p = 0.433).   
 No significant group x time interactions were observed for changes in IL-1β (F = 
0.47, p = 0.849, η2 = 0.027), however a significant time effect was observed (F = 17.57, p 
< 0.001, η2 = 0.341).  Pairwise comparisons indicated that when collapsed across groups, 
significant elevations (p’s < 0.001) from PRE (4.23 ± 2.34 pg/ml) were observed at IP (7.55 
± 5.77 pg/ml) and 1H (6.67 ± 4.89 pg/ml), 5H (4.79 ± 3.52 pg/ml), 24H (4.19 ± 2.91 pg/ml), 
48H (3.97 ± 3.34 pg/ml) and 96H (3.71 ± 2.39 pg/ml).  When compared to 5H, IL-1β 
concentrations trended to be lower at 48H (p = 0.08) but significantly lower at 96H (p = 
0.015).  No significant differences were observed in the IL-1β AUC response between 
groups (F = 0.101; p = 0.904). 
 No significant group x time interaction was observed for IL-6 (F = 1.018, p = 0.422, 
η2 = 0.055), however a significant time effect was observed (F = 4.801, p = 0.002, η2 = 
0.121).  When groups were collapsed, pairwise comparisons indicated a significant 
increase in IL-6 concentration from PRE (33.2 ± 42.9 pg/ml) at IP (35.2 ± 44.7 pg/ml; p = 
0.044), 1H (37.7 ± 48.7 pg/ml; p = 0.004) and 5H (42.5 ± 51.4 pg/ml; p = 0.002).  
Additionally, 5H was significantly elevated compared to 24H (38.4 ± 49.8 pg/ml; p = 
0.001), 48H (37.1 ± 50.1 pg/ml; p = 0.003) and 96H (28.0 ± 31.6 pg/ml; p = 0.010).  
Furthermore, no significant differences were observed in the IL-6 AUC response between 
the groups (F = 0.815, p = 0.451).   
 No significant group x time interaction (F = 0.801, p = 0.532, η2 = 0.044) was 
observed for IL-10, however, a significant main effect of time was observed (F = 5.608, p 
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= 0.005, η2 = 0.138).  Pairwise comparisons indicated that when groups were collapsed, 
IL-10 concentrations were significantly elevated at 1H (21.09 ± 15.16 pg/ml) compared to 
PRE (12.84 ± 14.67 pg/ml, p < 0.001), IP (16.80 ± 14.93 pg/ml; p = 0.009), 5H (14.45 ± 
19.41 pg/ml; p = 0.012), 24H (13.15 ± 14.79 pg/ml; p < 0.001), 48H (13.08 ± 15.38 pg/ml; 
p < 0.001), and 96H (11.39 ± 11.24; p < 0.001).  In addition, IL-10 concentrations at IP 
were significantly higher than PRE (p = 0.001), 24H (p = 0.008), 48H (p = 0.018) and 96H 
(p = 0.002).  The IL-10 AUC response between groups was not different (F = 2.178, p = 
0.128).   
 No significant group x time interaction (F = 0.876, p = 0.534, η2 = 0.052) was 
observed for G-CSF, however a significant main effect for time was observed (F = 7.415, 
p < 0.001, η2 = 0.188).  When groups were collapsed, pairwise comparisons indicated 
significant elevations from PRE (72.3 ± 37.0 pg/ml) at IP (92.2 ± 55.6; p < 0.001), 1H 
(84.9 ± 40.7 pg/ml; p = 0.011) and 5H (80.8 ± 36.3 pg/ml; p = 0.025).  Additionally, IP, 
1H and 5H were significantly greater than 24H (71.3 ± 40.5 pg/ml; p = 0.001, p = 0.006, p 
= 0.001, respectively), 48H (70.6 ± 49.1 pg/ml; p = 0.003, p = 0.004, p = 0.001, 
respectively) and 96H (65.8 ± 28.3 pg/ml; p = 0.001, p = 0.001, p < 0.001, respectively).  
No significant between group differences were observed for the G-CSF AUC response (F 
= 0.146, p = 0.732).   
 No significant group x time interactions were observed for GM-CSF (F = 0.501, p 
= 0.863, η2 = 0.028), however, a significant main effect for time was observed (F = 8.238, 
p < 0.001, η2 = 0.192).  When groups were collapsed, pairwise comparisons indicated a 
significant elevation from PRE (54.99 ± 51.38 pg/ml) at IP (75.36 ± 94.35 pg/ml, p < 0.001) 
and 1H (73.31 ± 98.20 pg/ml, p = 0.007).  GM-CSF was also significantly greater at IP and 
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1H than 5H (68.40 ± 87.97 pg/ml; p = 0.013, p = 0.049, respectively), 24H (61.48 ± 78.97 
pg/ml; p < 0.001, p = 0.001, respectively), 48H (59.86 ± 70.52 pg/ml; p < 0.001, p = 0.001, 
respectively) and 96H (52.56 ± 62.91 pg/ml; p < 0.001, p < 0.001, respectively).  In 
addition, GM-CSF concentrations at 5H were significantly greater than 48H (p = 0.049) 
and 96H (p = 0.040).  No significant differences were noted between the groups in the GM-
CSF AUC response (F = 0.315, p = 0.732).   
 No significant group x time interactions (F = 1.169, p = 0.321, η2 = 0.063 and F = 
0.385, p = 0.855, η2 = 0.022), were observed for changes in IL-8 and INF-γ concentrations, 
respectively.  In addition, no differences were noted in the AUC response (F = 0.122, p = 
0.885, and F = 0.365, p = 0.697, respectively) for these cytokine markers as well.   
 
Plasma Volume Shifts 
   A significant group x time interaction was observed for changes in plasma volume 
(F = 10.94, p < 0.001, η2 = 0.378).  Changes in plasma volume at IP were significantly less 
in CON (-1.4 ± 4.6%) compared to PPB (-17.7 ± 5.8%; p < 0.001) and PL (-15.1 ± 4.3%; 
p < 0.001).  Furthermore, PL (0.7 ± 3.7%) was significantly greater than PPB (-4.0 ± 7.3%; 
p = 0.037) and CON (-4.5 ± 5.8%; p = 0.028).  Circulating markers were not corrected for 




Leukocyte Population Distributions 
 Changes in the proportion of granulocytes in circulation in response to resistance 
exercise are depicted in Figure 13.  A significant group x time interaction was observed in 
the proportion of circulating granulocytes (F = 5.150, p < 0.001, η2 = 0.233).  Granulocyte 
proportions at IP were significantly higher in CON compared to PPB (p = 0.004).  
Furthermore, a trend towards a difference was noted at IP between CON and PL (p = 
0.073).  Additionally, the proportion of granulocytes in CON at 5H was significantly lower 
compared to PPB (p = 0.022) and PL (p = 0.013).  Granulocyte proportion for PL was 








Figure 13: Circulating Granulocyte Proportions following Resistance Exercise. 
Supplement (PPB), placebo (PL) and control (CON) groups were analyzed for 
changes in the circulating granulocyte proportions pre exercise (PRE), as well as 
immediately (IP), one- (1H), five- (5H), 24- (24H), and 48- (48H) hours post 
exercise. 
* Significantly different than corresponding value for PRE (p < 0.05) 
^ Significantly different than corresponding value for CON (p < 0.05) 
# Significantly different than corresponding value for PL (p < 0.05) 
 
 Changes in monocyte subset distributions in response to resistance exercise are 
depicted in Figure 14.  A significant group x time interaction was observed for the 
proportion of classical monocytes of the total monocyte population (F = 0.9552, p < 0.001, 
η2 = 0.381).  The proportion of classical monocytes were significantly greater in CON at 
IP compared to PPB (p = 0.008) and PL (p = 0.003).  Furthermore, classical monocytes 
were significantly reduced in CON at 1H compared to PPB (p = 0.002) and PL (p = 0.006).   
 A significant group x time interaction was observed for the proportion of 

































The proportion of intermediate monocytes were significantly lower in CON at IP compared 
to PPB (p = 0.034) and PL (p = 0.001).  Furthermore, this response was reversed at 1H 
with significantly greater proportions of intermediate monocytes in CON compared to PPB 
(p = 0.003) and PL (p = 0.008).  At 24H, the proportion of intermediate monocytes in CON 
were significantly lower compared to PPB (p = 0.016), and trended towards difference in 
PL (p = 0.094).  At 48H, the proportion of intermediate monocytes in CON were 
significantly lower compared to PPB (p = 0.007) and PL, and PL trended to be lower than 
PPB (p = 0.079).   
 A significant group x time interaction was also observed for the proportion of 
nonclassical monocytes of the total monocyte population (F = 6.543, p < 0.001, η2 = 0.297).  
The proportion of intermediate monocytes at IP was significantly lower in CON compared 




Figure 14: Monocyte Subtype Proportions following Resistance Exercise. 
Supplement (PPB), placebo (PL) and control (CON) groups were analyzed for changes in the monocyte subtype proportions 
pre exercise (PRE), as well as immediately (IP), one- (1H), five- (5H), 24- (24H), and 48- (48H) hours post exercise. 
* Significantly different than corresponding value for PRE (p < 0.05) 
^ Significantly different than corresponding value for CON (p < 0.05) 
 



























































Leukocyte Subtype Activation 
 Significant differences were observed between groups at PRE for CD11b 
expression on granulocytes (F = 5.334, p = 0.010), intermediate monocytes (F = 3.594, p 
= 0.039) and nonclassical monocytes (F = 7.942, p = 0.002).  As such, analyses between 
groups for expression of CD11b on all leukocyte subsets were analyzed as the percent of 
resting values (PRE set at 100%).   
 No significant group x time interaction was observed for the percent change in 
CD11b expression on granulocytes (F = 1.022, p = 0.421, η2 = 0.057), however a significant 
main effect for time was observed (F = 12.059, p < 0.001, η2 = 0.262).  When collapsed 
across groups , pairwise comparisons indicated that the change in expression of CD11b on 
granulocytes from PRE to IP (121.6 ± 30.1%; p < 0.001) and 1H (110.5 ± 24.9%; p = 
0.015) were significant, while a trend for a significant change in CD11b on granulocytes 
from PRE to 24H (106.9 ± 23.6%; p = 0.086) was also observed.  Additionally, the change 
from PRE to IP was significantly greater than the change from PRE to 1H (p = 0.001), 5H 
(99.5 ± 24.3%; p < 0.001), 24H (p = 0.001) and 48H (96.1 ± 19.9%; p < 0.001).  
Furthermore, the change in CD11b expression on granulocytes from PRE to 1H was 
significantly greater than the change from PRE to 5H (p = 0.016) and 48H (p = 0.001).   
 No significant group x time interaction was observed for the percent change in 
expression of CD11b on classical monocytes (F = 1.788, p = 0.111, η2 = 0.101), however 
a significant main effect time was observed (F = 9.663, p < 0.001, η2 = 0.232).  When 
collapsed across groups, pairwise comparisons indicated that the change from PRE to 1H 
(130.7 ± 29.8%), 5H (111.2 ± 28.8%), and 24H (113.5 ± 25.9%) were significant (p < 
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0.001, p = 0.033, p = 0.004, respectively).   Additionally, the change of CD11b expression 
from PRE to 1H was significantly greater than the change from PRE to IP (109.4 ± 33.4%; 
p < 0.001), 5H (p = 0.004), 24H (p < 0.001) and 48H (102.3 ± 20.7%; p < 0.001), while 
the change from PRE to 24H was significantly greater than the change from PRE to 48H 
(p = 0.002).   
 No significant group x time interaction was observed for the percent change of 
CD11b expression on intermediate monocytes (F = 1.859, p = 0.083, η2 = 0.104), however 
a significant main effect of time was observed (F = 5.667, p = 0.001, η2 = 0.150).  When 
collapsed across groups, pairwise comparisons revealed the change from PRE to 1H (116.6 
± 20.7%) was significant (p < 0.001), while the change from PRE to 24H trended toward 
significance (105.8 ± 18.3%; p = 0.070).  Additionally, the change from PRE to 1H was 
significantly greater than the change from PRE to IP (104.9 ± 26.55%; p = 0.003), 5H 
(102.0 ± 23.0%; p = 0.001), 24H (p = 0.001) and 48H (100.5 ± 15.9%; p < 0.001).  
Additionally, the change in expression of CD11b at from PRE to 24H was significantly 
greater than the change from PRE to 48H (p = 0.029). 
No significant group x time interaction (F = 1.917, p = 0.084, η2 = 0.107), nor main 
effect of time (F = 2.099, p = 0.104, η2 = 0.062) was observed for the percent change of 
CD11b expression on nonclassical monocytes; however, a significant main effect for group 
(F = 4.409, p = 0.020, η2 = 0.216) was observed.  Pairwise comparisons indicated that the 
average percent change from PRE to all time points in CD11b expression on nonclassical 
monocytes was lower in CON (89.1 ± 13.4%) compared to PPB (106.0 ± 13.8; p = 0.006), 
while no differences were observed between CON or PPB and PL (97.6 ± 12.3%; p = 





 Significant correlations were observed between markers of muscle damage and 
changes in CD11b expression on leukocyte subsets.  CK concentrations at 24H were 
significantly correlated with the change in CD11b expression on intermediate monocytes 
at IP (r = 0.439, p = 0.001), and nonclassical monocytes at IP (r = 0.413, p = 0.017), 1H (r 
= 0.392, p = 0.024) and 5H (r = 0.374, p = 0.032).  Furthermore, 48H CK concentrations 
were significantly correlated with the change in CD11b expression at IP on granulocytes 
(r = 0.340, p = 0.045), classical monocytes (r = 0.365, p = 0.037), and intermediate 
monocytes (r = 0.452, p = 0.008).  Additionally, the change in CD11b expression on 
nonclassical monocytes was correlated at IP (r = 0.450, p = 0.009), 1H (r = 0.402, p = 
0.020), 5H (r = 0.345, p = 0.049), 24H (r = 0.446, p = 0.009) and 48H (r = 0.495, p = 
0.003).  No correlations were observed between the change of CD11b expression on 
leukocytes and myoglobin AUC.  Correlations with leukocyte subset proportions are 
displayed in Table 4. 
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Table 4: Leukocyte Subset Correlations with Markers of Muscle Damage 
 
  Myoglobin AUC 24H CK Concentration 48H CK Concentration 
    GRAN CLASS INTER NC GRAN CLASS INTER NC GRAN CLASS INTER NC 
IP 
r -0.515 -0.664 - 0.775 -0.635 -0.692 - 0.719 -0.565 -0.583 0.399 0.555 
p 0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 0.024 0.001 
1H 
r -0.374 -0.359 - 0.535 - - - - - - - - 
p 0.025 0.040 0.001 
5H 
r 
- -0.548 - 0.568 - -0.361 - - - - - - 
p 0.001 0.001 0.042 
24H 
r 
- -0.543 - 0.609 - -0.466 - 0.434 - -0.434 0.380 - 
p 0.001 <0.001 0.007 0.013 0.013 0.032 
48H 
r -0.408 -0.640 0.412 0.631 - -0.565 0.452 0.471 - -0.457 0.387 0.361 





CHAPTER 5: DISCUSSION 
 
The results of this study demonstrated significant alterations in the monocyte 
proportions following acute resistance exercise.  Exercise produced significant 
mobilization of intermediate and nonclassical monocyte subtypes immediately following 
resistance exercise, followed by a supercompensation of the classical subset.  As expected, 
resistance exercise stimulated an increase of MCP-1 concentrations immediately following 
exercise, but our results indicated a biphasic response occurring at 5H.  Furthermore, 
CD11b expression was elevated on granulocytes immediately following resistance 
exercise, and remained elevated for one hour.  Classical and intermediate monocytes 
increased expression of CD11b 1-hr following exercise, while only classical monocytes 
maintained this elevated expression for 24-hr.  Our results also suggest that polyphenol 
supplementation enhanced the CD11b response to exercise on nonclassical monocytes. 
Lower resting expressions of CD11b on intermediate and nonclassical monocytes in PBB 
compared to PL and CON suggest that supplementation may have suppressed this immune 
marker.  Markers of muscle damage, resulting from the exercise protocol, were greater with 
polyphenol supplementation, and moderately correlated to leukocyte subset distributions, 
as well as to CD11b expression following exercise (r = 0.359 to 0.775). 
 Skeletal muscle damage produces a potent immune response, characterized by an 
increased accumulation of phagocytic cells within the damaged tissue (Tidball & Villalta, 
2010).  MCP-1 plays an integral role in the acute immune response by serving as the 
primary chemoattractant for classical monocytes (Wong et al., 2012; Yadav et al., 2010).  
Our results indicated that resistance exercise may mediate a biphasic response of MCP-1 
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to resistance exercise, characterized by an initial increase immediately following exercise, 
and a second, larger increase at 5H.   
To the best of our knowledge, only two investigations have examined the acute 
response of circulating MCP-1 following dynamic resistance exercise (Ihalainen et al., 
2014; Wells et al., 2016).  The immediate increase of MCP-1 observed in this study is in 
contrast to the decrease in MCP-1 concentration reported 30-min following resistance 
exercise in untrained men (Ihalainen et al., 2014).  However, it is similar to the immediate 
increase reported following a lower body resistance exercise protocol in resistance trained 
men (Wells et al., 2016).  While Ihalainen et al. (2014) utilized a similar population as this 
study (e.g., previously untrained men), the exercise stimulus used multiple sets of a single 
leg press exercise only.  In contrast, this study required participants to exercise with 
multiple lower body exercises, similar to Wells and colleagues (2016).  The greater volume 
of repetitions performed in this study (140 total repetitions compared to 50 in the Ihlalainen 
et al study) suggest that the immediate increase in MCP-1 following resistance exercise 
may be driven by volume of exercise, and may be independent of training status.  The 
biphasic response observed though, was absent from any previous study examining the 
MCP-1 response to resistance exercise (Ihalainen et al., 2014; Wells et al., 2016).  
However, investigations examining exercise interventions designed to elicit muscle 
damage have observed the secondary response approximately 5-hr into recovery (Crystal 
et al., 2013; Paulsen et al., 2005).  Furthermore, the participants used in those studies were 
moderately trained (Crystal et al., 2013; Paulsen et al., 2005), and comparable to the 
participants used in this study.  Therefore, the biphasic response of MCP-1 may also be a 
function of both volume in conjunction with unaccustomed muscle action.   
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The recruitment of other monocyte subsets is governed primarily by CX3CL1 
(Bazan et al., 1997).  Circulating CX3CL1 concentrations increased at both IP and 1H for 
all groups combined.  These results were similar to others that reported increases in 
circulating CX3CL1 concentrations for two hours following unilateral cycling (Catoire et 
al., 2014).  These investigators also reported a significant increase in mRNA expression of 
CX3CL1 within skeletal muscle immediately after exercise.  Significant increases of 
CX3CL1 mRNA has also been reported two hours post-resistance exercise (Della Gatta et 
al., 2014) Although Della Gatta and colleagues (2014) did not examine changes in 
CX3CL1 concentrations following exercise, they did indicate that mRNA expression 
returned to baseline levels at 4-hr post-exercise.  CX3CL1 is synthesized by endothelial 
cells (Ludwig et al., 2002), and will remain bound to the endothelial surface unless cleaved 
in the presence of TNF-α and IL-1β (Turner et al., 2010).  Interestingly, the results of this 
study indicated that IL-1β was elevated concomitantly with CX3CL1 at both IP and 1H.  It 
is likely that elevations in circulating CX3CL1 concentrations were related to the 
elevations observed in IL-1β.     
IL-8 is also a potent chemoattractant for phagocytic cells, namely neutrophils 
(Ribeiro et al., 1991).  However, we saw no change in IL-8 concentrations in response to 
resistance exercise.  This is in contrast with some investigators (Nieman et al., 2004), but 
is supported by others (Buford et al., 2009).  Training status does not appear to have 
influenced these results, as most investigations utilized trained participants (Buford et al., 
2009; Nieman et al., 2004; Ross et al., 2010).  However, the volume of exercise used in 
this study (140 total repetitions) was less than that of Nieman and colleagues (2004) (four 
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sets of 10 repetitions in 10 different exercises), and may not have been sufficient to elicit a 
significant increase in IL-8 concentrations.     
Expansion of the granulocytic population in this study occurred despite the absence 
of any change in IL-8 concentrations.  This was a bit surprising considering IL-8 is a potent 
chemoattractant for neutrophils (Ribeiro et al., 1991).  However, the expansion of 
neutrophils, in the absence of increases of IL-8 in circulation has been reported previously 
(Paulsen et al., 2005), indicating the IL-8 response may not be necessary for granulocytic 
expansion.  In the present study, granulocytes appeared to make up a greater proportion of 
total leukocytes at 1H, 5H and 24H following exercise.  Selective expansion of the 
granulocyte population is well documented following resistance exercise (Miles et al., 
1998; Nieman et al., 2004; Ramel et al., 2003), and exercise designed to elicit muscle 
damage (Paulsen et al., 2005).  Evidence from a muscle damaging study has demonstrated 
neutrophils to return to baseline concentrations 24-hr following exercise (Paulsen et al., 
2005).  Despite this, granulocytes are thought to increase immediately following exercise 
for approximately two hours following resistance exercise (Freidenreich & Volek, 2012).  
Investigations examining resistance exercise typically do not report the overall granulocyte 
population following 24 hours of recovery in healthy participants (Miles et al., 1998; 
Nieman et al., 2004; Ramel et al., 2003).  The expansion of the granulocyte population at 
24H in this study, however, suggests that granulocytosis may be more prolonged following 
dynamic resistance exercise than previously reported. 
Mobilization of monocytes following resistance exercise has also been 
demonstrated in conjunction with granulocyte expansion (Mayhew et al., 2005; Nieman et 
al., 2004; Ramel et al., 2003).  The response of specific monocyte subtypes though, has yet 
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to be defined in regards to resistance exercise.  In this study, we observed the mobilization 
of both intermediate and nonclassical monocytes immediately following exercise at the 
expense of the classical monocyte subset.  While selective mobilization of the CD16+ 
subset may be induced by catecholamines (Kittner et al., 2002), the intensity of exercise 
also appears to drive this response (Steppich et al., 2000).  Previous investigations 
examining the monocyte response to exercise under the three subset paradigm have 
demonstrated this mobilization to be primarily from the nonclassical subset (Booth et al., 
2010; Radom-Aizik et al., 2014; Shantsila et al., 2012; Simpson et al., 2009).  LaVoy and 
colleagues (2015) demonstrated an increased proportion of both intermediate and 
nonclassical monocytes following aerobic exercise in a mixed gender group of participants.  
Women though appear to have a different response of nonclassical monocytes to exercise 
than men (Heimbeck et al., 2010).  Considering that participants in this study were men 
only, the increase in intermediate monocyte proportions observed immediately following 
exercise appears to be related to the resistance exercise protocol itself.   
Increases of intermediate monocytes at 24H and 48H following exercise occurred 
at the expense of the classical monocyte subset, with no change in the nonclassical 
proportion.  Furthermore, PPB demonstrated a significantly greater intermediate monocyte 
population than CON, with a trend compared to PL (p = 0.079) at 48H.  Although data 
from ischemic tissue damage has demonstrated significant elevations in intermediate 
monocytes 24 and 48 hours following injury (Tapp, Shantsila, Wrigley, Pamukcu, & Lip, 
2012; Urra et al., 2009),  there does not appear to be any previous investigation that has 
examined monocyte subsets in response to exercise 24 or 48 hours into recovery.  Tapp 
and colleagues (2012) have also reported that changes in intermediate monocytes were 
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associated with the extent of tissue damage.  Consequently, the increased intermediate 
monocyte proportion in PPB at 48H was likely a result of greater muscle damage.  
Furthermore, the significant correlations observed in this study (r = 0.380 to 0.452) 
between markers of muscle damage and the intermediate monocyte proportion at 24H and 
48H support the potential relationship between tissue damage and intermediate monocyte 
mobilization. 
 The coupling of CD11b with CD18 to form MAC1/CR3, and its involvement within 
the transendothelial migration process (Tan, 2012) makes CD11b a key regulator of 
phagocyte migration to damaged tissue (Ley et al., 2007).  Granulocytes migrate to 
damaged tissue within the first hours following exercise, monocytes tend to migrate later 
(Malm et al., 2000; Paulsen et al., 2010).  The increased CD11b expression on granulocytes 
at IP and 1H, followed by classical monocytes at 1H, 5H and 24H observed in this study is 
consistent with the temporal appearance of these cells within damaged tissue.  While the 
reported time course of CD11b expression on monocytes has been more consistent than on 
granulocytes, little consensus as to the time course of the granulocyte expression of CD11b 
has been developed (J. Peake et al., 2005).   
Investigations utilizing aerobic exercise (Jordan et al., 1999; van Eeden et al., 1999) 
and exercise designed to elicit muscle damage (J. M. Peake, K. Suzuki, G. Wilson, et al., 
2005; Pizza et al., 1996; Saxton et al., 2003) have previously examined CD11b expression 
on granulocytes.  However, no studies have examined the impact of dynamic resistance 
exercise on CD11b expression on granulocytes.  Our results indicate that resistance 
exercise can stimulate increases in CD11b expression on granulocytes at IP and 1H.  These 
results are similar to previous investigations examining endurance exercise protocols.  
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Various studies have reported significant increases immediately following exercise 
(Gabriel & Kindermann, 1998; Jordan et al., 1999; van Eeden et al., 1999), which may 
persist for up to 30-min post-exercise (van Eeden et al., 1999).  However, our results appear 
to differ in comparison to studies using eccentric exercise protocols.  Following downhill 
running, Peake and colleagues (2005) reported no changes in CD11b expression during the 
recovery period in well-trained men.  Similarly, studies examining 50 eccentric 
contractions of the quadriceps (Saxton et al., 2003) or 25 eccentric contractions of the 
elbow flexors (Pizza et al., 1996) in moderately trained men, reported no change in CD11b 
expression up to 24 hours post-exercise.  However, these latter studies first measured 
CD11b expression at 4- and 1.5-hr, respectively, post-exercise.  We observed an increase 
in the expression of CD11b on granulocytes at IP and 1H, which was prior to any of the 
measurements assessed by Saxton et al. (2003) or Pizza et al. (1996).  Pizza and colleagues 
(1996) though, did demonstrate a significant increase in CD11b expression 24 hours 
following their damaging protocol.  The results of this study provides some support as we 
indicated a trend for an increased expression at 24H (p = 0.086).   
  Expression of CD11b on monocytes has been more extensively examined than 
granulocytes.  Previous reports have demonstrated elevated CD11b expression on classical 
monocytes immediately and 1-hr post-exercise (Wells, et al. 2014).  Other investigations 
have reported no increase immediately, but significant increases 30-min following a similar 
exercise stimulus in trained men (Gonzalez et al., 2014; Jajtner et al., 2014).  The disparity 
in the time course reported between the studies may be due to the monocyte population 
examined.  Wells and colleagues (2016) analyzed classical monocytes only 
(CD14++/CD16-), while Jajtner et al. (2014) and Gonzalez et al. (2014) utilized CD14++ 
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monocytes without differentiating between classical and intermediate monocytes.  
Consequently, Wells et al. (2016) suggested that the response of CD14++ monocytes may 
have been influenced by intermediate monocytes, contributing to the lack of any change 
immediately post-exercise (Gonzalez et al., 2014; Jajtner et al., 2014).  The delayed 
increase of CD11b expression on intermediate monocytes in this study supports this 
suggestion.  However, the delayed expression of CD11b on classical monocytes observed 
from 1H to 24H contrasts with Wells et al. (2016).  Training status of the participants may 
explain the different results, as this study used untrained participants while Wells et al. 
(2016) investigated resistance-trained individuals.  This study also observed a significant 
increase in CD11b expression on classical monocytes at 24H.  Previous investigations have 
only examined CD11b expression on CD14++ following resistance exercise in trained men 
(Gonzalez et al., 2014; Jajtner et al., 2014).  This appears to be the first study to examine 
CD11b expression on monocyte subsets 24 and 48H following exercise. 
 Polyphenol supplementation (PPB) for 28 days also appeared to reduce CD11b 
expression on intermediate and nonclassical monocytes at rest compared to CON and PL.  
CD11b expression on monocytes was not examined prior to the onset of supplementation, 
therefore we can only speculate in relating this decreased expression of CD11b to 
polyphenol supplementation.  However, there does appear to be support for this from an in 
vitro model, which demonstrated a significant downregulation of CD11b, as well as 
reduced chemotaxis and adherence in response to incubation with polyphenols (Kawai et 
al., 2004; Takano et al., 2004).  However, others have suggested that decreases in CD11b 
expression on monocytes may have beneficial health benefits, as polyphenol associated 
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decreases in CD11b expression on monocytes has been previously reported to have 
potential beneficial effects in cardiovascular disease (Chiva-Blanch et al., 2012).   
In this study, no differences in the time course of CD11b expression were observed 
between groups for classical or intermediate monocytes.  However, participants in PPB 
demonstrated a greater change in CD11b expression on nonclassical monocytes during 48-
hr of recovery than CON.  While the expression of CD11b on nonclassical monocytes is 
reduced compared to other subsets (Cros et al., 2010; Wong et al., 2011; Zawada et al., 
2011), it is unclear why this difference occurred.  Nonetheless, the role of CD11b in 
transendothelial migration (Ley et al., 2007), and the propensity of nonclassical monocytes 
to polarize to M2 macrophages (Auffray et al., 2007) may indicate no deleterious effects 
on recovery.  Furthermore, it is unclear if reduced CD11b expression on classical and 
intermediate monocytes throughout the recovery process is detrimental to functional 
recovery.  Therefore, polyphenol supplementation may serve as a potential treatment 
option to decrease adherence and chemotaxis of monocytes, without affecting the exercise 
response; however, further research is warranted.     
 
Conclusions 
The present study investigated the impact of an acute bout of resistance exercise in 
untrained participants on the redistribution of monocyte subsets, as well as the expression 
of adhesion molecules on the surface of phagocytic cells.  Circulating MCP-1 
concentrations demonstrated a biphasic response to resistance exercise, with an initial 
increase immediately following exercise, and a second pronounced increase five hours into 
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recovery.  This appears to be the first study to report a sustained increase in the proportion 
of granulocytes in relation to total leukocyte population up to 24-hr post-resistance 
exercise.  The monocyte subset response to resistance exercise was characterized by a 
mobilization of intermediate and nonclassical monocytes immediately following exercise, 
followed by a supercompensation of classical monocytes 1-hr post-exercise.  This study 
also appears to be the first investigation to report a significant increase in the intermediate 
monocyte subset 24- and 48-hr following exercise.  Polyphenol supplementation, possibly 
due to increased muscle damage, increased the proportion of intermediate monocytes 48H 
following exercise.  The results of this study indicated that an acute bout of resistance 
exercise in untrained individuals elicits selective mobilization and adherence 
characteristics of phagocytic cells throughout recovery.  Polyphenol supplementation 
appears to augment the resting expression of CD11b, however, does not affect the exercise 
response of classical and intermediate monocytes, or granulocytes.
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